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ABSTRACT

Bai, Yunfeng, Ph.D., Purdue University, May 2015. Functional Study of Mammary
Epithelial Cell Architecture. Major Professor: Sophie Lelièvre.

Cell organization confers cellular identity and guides cellular functions. Here, the cell
organization is defined as the global arrangement of the functional complexes, which are
composed of proteins, nucleic acids, lipids, or the combinations of any of them, in the
cells. These functional complexes are arranged in a spatial and temporal manner, which
closely reflects and regulates cellular activities.Targeting two proteins that act as central
nodes in the nucleus, the nuclear mitotic apparatus protein, NuMA, and in the cytoplasm,
the CDP-diacylglycerol synthase 1, CDS1, I have studied their influences on two features
of the cell architecture, namely the nucleolus and the polarity axis, that play a major role
in the homeostasis of mammary epithelial cells and in cancerous development. The
nucleolus is an essential nuclear body with functions in ribosome biosynthesis, stress
perception, and cell cycle control. Basoapical polarity is the signature structure of the
differentiated epithelial cells and is functionally related to cell proliferation and survival.
By modulating the expression of NuMA or of CDS1 and assessing the resulting impact
on the nucleolus or the tissue polarity axis, respectively, my goal was to further the
understanding of the regulation and role of these architectural features in cell phenotypes.
I have shown in my major project that NuMA is involved in the control of nucleolar
architecture and rDNA transcription. I also showed in my minor project that CDS1
partially restores basal polarity depending on signaling in aggressive MDA-MB-213
cancer cells. I have placed these studies focused on cellular architecture in the context of
cancerprevention,fromitsonsettoprogression.
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CHAPTER 1: INTRODUCTION

1.1. Primary prevention of breast cancer
According to the estimation from the American Cancer Society (American Cancer
Society Inc., 2014), about 232,670 new cases of invasive breast cancer and 62,570 extra
cases of in situ breast cancer will be diagnosed in American women in 2014. Among the
patients diagnosed in 2014, approximately 40,000 will die from breast cancer that same
year. Worldwide, about 1.67 million new cases of breast cancer were predicted in 2012
and

half-a-million

of

lives

were

to

be

lost

(http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx). Considering these diagnosed
patients are mothers, wives, daughters, and sisters, millions of people’s lives have been or
will be greatly affected not only physically but also psychologically and economically.
Beyond the physical and psychological suffering, which is difficult to quantify, the
estimated global economic loss from breast cancer was $88 billion in 2008, representing
0.15% of the world’s gross domestic product of that year (American Cancer Society and
LIVESTRONG, 2010). This economic loss does not even include the direct medical cost
of the treatment of breast cancer.
As a devastating disease it still is, our society already has accomplished great
strides during the long fight with breast cancer. Statistical data from the National Center
for Health Statistics and Centers for the Disease Control and Prevention show that
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mortality from breast cancer has steadily decreased annually by 1.8% in white, 1.6% in
African American, 1.7% in Hispanics, and 1% in Asians/Pacific Islanders during 20012010 in the United States; it is unchanged in American Indians/Alaska Natives (American
Cancer Society Inc., 2014). The dropdown of the mortality is attributed to improved
treatment and widely applied screening. The overall breast cancer incidence has kept
increasing until remained stable since 2004 in the USA, but unfortunately, the rising
trend

is

not

changed

in

most

(http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx).

developing
With

no

doubt,

countries
decreased

mortality is partially due to the improved treatment as well as cancer screening that have
attracted most funding resources. Treatment and screening are exclusively dealing with
tumors already formed in the patients’ body; therefore, these efforts could not affect
breast cancer incidence, and the same large number of people still have to suffer from the
disease. Primary prevention is the only way to reduce the incidence and the great damage
from the disease because it is targeting the reduction of breast cancer occurrence.
Is breast cancer preventable and if so, how? Although the underlying mechanisms
of cancer initiation remain largely unknown, existing evidence strongly supports the idea
that breast cancer can be prevented to some extent. Studies on native Asians or AsianAmericans (Ziegler, Hoover et al. 1993) have connected the substantial increased risk of
breast cancer with the adoption of western lifestyles. The results clearly suggested that
the potential risk factors encompass more than the long-known genetic predisposition and
carcinogens. Encouragingly for primary prevention research, these lifestyle-related risk
factors are controllable, which will provide methodology for practice. To this date, many

3
risk factors have been identified and are categorized as non-modifiable factors (gender,
age, personal and family history of breast cancer, and personal physical conditions) and
modifiable factors including both lifestyle-related factors (postmenopausal hormone use,
obesity, physical activity, diet, alcohol, tobacco, and oral contraceptive use) and other
factors (exposure to radiation, specific chemicals, environmental pollution, and specific
occupations). More detailed studies about the relative risk for each factor have been
reviewed (Colditz and Bohlke 2014). It should be noted that primary prevention
strategies can be designed for application not only to modifiable risk factors but also to
some non-modifiable factors. For example, a study showed that treatment with
Tamoxifen reduced the risk of Estrogen Receptor positive (ER+) invasive and in situ
breast cancer by 42% in women with family history of breast cancer, and thus considered
at increased risk for breast cancer (Fisher, Costantino et al. 1998).

Prophylactic

mastectomy is also considered as a particular primary prevention strategy for women
with genetic BRCA1 or BRCA2 mutation. Ideally, the strategies of primary prevention
should be simple, painless, and less expensive than detection and treatment. With an
enhanced understanding of the risk factors in the future, personalized design of primary
prevention strategies is expected to play an increasingly important role in the battle
against breast cancer.
Yet, one awkward situation that the primary prevention of breast cancer field has
to face is that most essential but non-modifiable risk factors, such as aging, being female,
and family history of breast cancer, seem to be unpreventable at present. Furthermore, for
most of modifiable lifestyle-related risk factors, like alcohol use, the predicted preventive
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efficacy can be only expected in populations rather than the individual cases. These
issues are actually addressing the same fundamental aspect of the current state of primary
prevention research, i.e. our large knowledge gap between the risks and true cancer
occurrence. Rome wasn’t built in a day, so wasn’t the aggressive cancer. A series of
errors and abnormal activities have to accumulate to transit a normal cell into a cancer
cell and logically, these mistakes should be accompanied with morphological alterations
occurring at different levels during tumorigenesis. Cancer is a disease arising from cells
that have lost proliferation control. Therefore, understanding the molecular and cellular
activities that promote cell proliferation and the related morphological changes at
molecular, cellular, and tissue levels will help filling the knowledge gap between risk and
cancer initiation. In addition, characterization of the morphological abnormalities of the
cells and tissue in pre-cancer and progression stages will also benefit early diagnosis of
breast cancer. The mostly applied method for breast cancer screening at present is
mammography, which enables the detection of tumor at median size 1.0 – 1.5 cm (Guth,
Huang et al. 2008). Better characterization of pathological alterations in early stage
cancer nodules will improve the accuracy of cancer diagnosis and provide valuable
information for the appropriate treatments of these small tumors.
To achieve these goals we need a better understanding of the cell architecture.
The concept of cell architecture here is defined as the characteristic arrangement of
cellular complexes based on their function cell-wide under normal physiological
condition. The cellular functional complexes can be any entities, comprising proteins,
nucleic acids, lipids or their combinations, carrying out certain biological functions and
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displaying a distinct ‘geographic’ pattern in a spatial and temporal manner. To be more
specific, mammary epithelial cells in the normal breast tissue always display a typical
architecture conveyed by cell polarity and nuclear organization, which defines their
identity and functions to be different from other types of cells (Lelievre 2010; Grafton,
Wang et al. 2011).
1.2. Mammary epithelial polarity as a cell quiescence controlling machinery
It is a well-accepted rule that structure determines function in the inorganic world
as well as in organic chemistry; however, in living organisms, this rule is compromised
by the evolution.

In fact, after long-term natural selection over random genetic

mutations, the relationship between structure and function in modern organisms is
accustomed to the mode of mutual adaptation. The interdependent nature of structure and
function in the body allows for any change on one side to influence the other side, which
can be evidenced by the diseased organs, tissues, and cells in the body.
Human breast consists of mammary glands, where breast cancer occurs,
surrounded by fatty and connective tissues. The mammary gland is a highly organized
tissue composed of two basic units, namely the acinus and the duct. The acinus is a
sphere-like structure with a single continuous layer of luminal epithelial cells that secrete
milk proteins during the lactation period and a discontinuous layer of myoepithelial cells
lining the luminal cells against the stroma to expel milk into the duct. Through a small
duct called terminal duct, several acini are connected to larger ducts branched to other
ducts also terminated by groups of acini to form a lobular structure similar to a bunch of
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grapes. There are about 8-15 of such ductal systems or lobes in each breast that each open
via an enlarged duct at the nipple.
Depending on where the lesion grows, breast epithelial proliferative diseases are
mainly classified into two types, lobular and ductal. Based on whether the basement
membrane is infiltrated or not, breast epithelial proliferative diseases are categorized as
pre-invasive and invasive stages. Accordingly, the morphological characteristics for each
type of lesion have been well documented and are used for clinical diagnosis. But as
mentioned above, the earlier the disease stage, the less we know. Hyperplasia is
considered to happen prior to carcinoma in situ, both of which are pre-invasive stages.
Histological analysis of hyperplasias has revealed that there is a disruption of normal
mammary gland architecture. The most prominent change is the replacement of the single
layer of luminal epithelium by a multilayered epithelium due to the increased number of
cells in the lumen. Studies also suggested a slight increase of risk of invasive carcinoma
from both usual hyperplasia and atypical hyperplasia (Elston and Ellis 1991).
It is not known how hyperplasia initiates, yet a clear clue is that the lesion sites
contain more cells than in normal conditions, which likely implies somewhat of a loss of
proliferation control in a portion of the cell populations. With the exception of pregnancy
and lactation, most mammary epithelial cells maintain quiescence. The resting normal
epithelium displays the unique tissue architecture, namely basal-apical polarity. It is
defined by the location of tight junctions (TJ) at the apical side of cell-cell contacts
against the lumen, while at the basal side exemplified by cell-extracellular matrix
contacts α6β4 integrin dimers accumulate against the basement membrane. Basal polarity
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functions in anchorage and signal exchange between cells and their surrounding
extracellular matrix. Impaired basal polarity will induce cell anoikis (Eble and Haier
2006). The classical function for apical polarity is to block the diffusion of small
molecules, such as proteins and fat, along the cell membrane of luminal cells (Krug,
Schulzke et al. 2014). But lately studies also uncovered its role in cell homeostasis
maintenance and proliferation control.
Tight junctions seal two adjacent epithelial cells at the apical pole through the
interaction of three transmembrane proteins claudins, occludins, and junctional adhesion
molecule (JAM) produced by each neighboring cell. The appropriate localization,
assembly, and function of TJ are supported by many other interacting protein complexes
under the cell membrane and, together, they are referred as the apical junctional complex
(AJP) (Lelievre 2010). Currently identified members that regulate TJ formation are
Crumbs3/Pals-1/PATJ

complex,

PAR-6/PAR-3/aPKC/Cdc42

complex,

and

Scrib/DLg/Lgl. Zonula Ocluden (ZO)-1/ ZO-2/ZO-3 proteins that provide the scaffold of
TJ and mediate the connection of TJ to cytoskeletal F-actin. More information on AJP
regulators and their functions can be found in a recent review (Van Itallie and Anderson
2014).
Studies in Drosophila indicate that tight junctions form after adherens junctions
(Lelievre 2010). Unfortunately the tight junction feature is difficult to reproduce in cell
culture. Among numerous human mammary epithelial cell lines that still maintain
adherens junctions as well as basal polarity, the non-neoplastic HMT-3522 S1 cell line is
one of the very few models that recapitulate apical tight junctions as indicated by staining
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for tight junction markers ZO-1, ZO-2, Par3, and Pasl-1 under three dimensional (3D)
cell culture conditions (Plachot, Chaboub et al. 2009). It seems that the architecture of
apical polarity is extremely sensitive to environmental/cell functional changes compared
to lateral and basal structures of polarity. Indeed, the fragility of apical polarity is
understandable given the involvement of the ever-increasing number of proteins
identified at the APJ. Accordingly, it is not surprising to witness the profound influence
that the disruption of apical polarity has on cellular activities when the interactions
among different APJ proteins go awry. Work from our laboratory has demonstrated that
acini produced in 3D culture to display impaired apical polarity contain cells primed to
enter the cell cycle, as indicated by the expression of the cell cycle marker Ki67 upon
stimulation, compared to cells contained in acini with intact apical polarity
(Chandramouly, Abad et al. 2007). We have hypothesized that apical polarity is a barrier
for functionally differentiated mammary epithelial cells to enter the cell cycle upon
environmental stimuli. The effect of apical polarity loss to facilitate proliferation could be
caused by different mechanisms. The intact AJP is an apparatus composed of proteins
important for transcription activity, epigenetic modification, and signal transduction
(Gonzalez-Mariscal, Dominguez-Calderon et al. 2014). Thus, the presence of apical
polarity possibly acts as a symbol of functional balance among various signaling
pathways.
The functional complexity of apical polarity is further evidenced by a microarray
study on acini produced in 3D culture with apical polarity disrupted through two different
methods conducted by our laboratory. An overlap of thirty genes with transcriptional
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changes upon apical polarity disruption has been identified, with genes belonging to
distinct groups based on their functions including transcription factors, epigenetic
modifiers, and signal transducers. Of particularly interest, a gene CDS1 involved in lipid
metabolism was also identified (Cardenas JM, Ph.D. Thesis, 2012).
1.3. Lipid metabolism in cancer cells and the potential influence on polarity
CDS1 was identified in our earlier work to be down-regulated upon the disruption
of apical polarity in a 3D cell culture model mimicking the differentiated mammary
epithelium. Its protein product is the cytidine diphosphate-diacylglycerol (CDP-DAG)
synthetase 1 responsible for the production of phosphatidylinositols (PI) from
phosphatidic acid (PA) (Lykidis, Jackson et al. 1997).

The CDP-DAG pathway

possesses a unique position and essential functions in the whole lipid metabolism
network. The de novo synthesis of PA, the upstream substrate of CDS1, uses glucose-6phosphate and fatty acid (FA) as substrates; thus it connects the glycolysis pathway and
the FA synthesis pathway (Baenke, Peck et al. 2013). The CDP-DAG pathway also
generates PI, phosphatidylglycerol (PG), and cardiolipin downstream products,
suggesting that it mediates multiple biological functions. By all means, CDS1 should be
an ideal example to study the influence of the metabolism, especially lipid metabolism,
on tissue architecture and cancer development.
Deregulated cellular metabolism in cancer cells has gained more and more
attention in recent years thanks to the implementation of several high throughput
techniques, like chromatin immunoprecipitation followed by sequencing (ChIP-seq) and
liquid chromatography/mass spectrometry (LC-MS). Because of its indispensable role in
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supporting rapid cell proliferation, energetic metabolism reprogramming has been
considered as an emerging hallmark of cancer (Hanahan and Weinberg 2011). Perhaps
the most seminal observation linking metabolism to cancer is the “Warburg effect”
proposed in 1920s and revealing that glucose is mainly consumed in a low-ATPgenerating way, namely aerobic glycolysis, in cancer cells compared to the much more
efficient oxidative phosphorylation in differentiated cells (Warburg 1956; Gatenby and
Gillies 2004). Noteworthy, the switch to aerobic glycolysis was also discovered in some
types of non-neoplastic proliferating cells in recent studies (Vander Heiden, Cantley et al.
2009). The reason for cancer cells metabolizing glucose primarily through aerobic
glycolysis remains elusive, but it is believed to generate more intermediates to meet the
needs for the synthesis of macromolecules, like nucleic acid and lipids, in rapidly
dividing cells. The cause-or-consequence debate regarding altered metabolism in cancer
development lasted until the identification of cancer-associated metabolic enzymes that
include tumor suppressor genes fumarate hydratase (FH), succinate dehydrogenase
(SDH), and oncogene isocitrate dehydrogenase (IDH) (Losman and Kaelin 2013), as well
as the most recent finding of histone deacetylase SIRT6 that controls cancerous
metabolism activation (Sebastian, Zwaans et al. 2012). These studies have strongly
supported the driver role of dysfunctional metabolism in tumorigenesis.
Together with major glucose metabolic pathways switched to aerobic glycolysis
in cancer, de novo fatty acid (FA) biosynthesis is also recognized in many cancer tissues
as the hallmark of dysfunctional lipid metabolism (Menendez and Lupu 2007). In healthy
adult organisms and most tissues (except for liver, adipose tissue and lactating breast), de
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novo FA biosynthesis shuts down or is only maintained at basal level because cell fatty
acids are mostly acquired from the bloodstream; however, such biosynthesis is
reactivated in many cancer cells even if enough circulating FAs are present in the
microenvironment (Menendez and Lupu 2007). Again, the reason for FA metabolism
network redirection is arguably to meet the dividing demands from cancer cells, but that
is apparently not the only explanation (Hopperton, Duncan et al. 2014).
Lipids refer to a large group of compounds with diverse structures; roughly, they
can be considered as the collection of fatty acids, their derivatives and substances related
biosynthetically or functionally to these compounds. Fatty acids are naturally synthesized
via condensation of malonyl coenzyme A units by a fatty acid synthase complex. They
usually contain even numbers of carbon atoms in straight chains (commonly C14 to C24),
and may be saturated or unsaturated; they can also contain other substituent groups (the
AOCS lipid library, http://lipidlibrary.aocs.org/Lipids/whatlip/index.htm). The large
variety of functions for lipids (membrane constituents, signaling molecules, energy
storage components, etc.) raises the question of how they influence cancer development.
To address this question, I would like to first review some specific FAs known to be
associated with breast cancer occurrence; then move to the regulatory proteins and
enzymes important for cancer formation in de novo FAs biogenesis pathway; and, at last,
I will discuss current knowledge about the potential link between lipid metabolism and
mammary polarity.
Epidemiological data have connected higher breast cancer incidence to higher
consumption of ω-6 FAs and lower incidence to higher uptake of ω-3 FAs. These results
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unveiled a very interesting pattern between global geographical distribution of higher
breast cancer incidence and local diet spectrum regarding the FA types. Namely, foods
with higher ω-3 FAs are preferred in the eastern world with lower breast cancer
incidence, while high incidence-associated ω-6 FAs enriched diet is prevalent in the
western world (Cardenas, JM. Ph.D. Thesis, 2012). The different risk effects on breast
cancer incidence from different types of FA have attracted much attention for their
potential values in primary prevention. In an effort to understand the preventive effect of
FAs, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA),
extensive studies have been conducted in different cancer models. While the underlying
mechanism remains elusive, results showed that ω-3 FAs play inhibitory roles on almost
all aspects of the hallmarks of cancer (Stephenson, Al-Taan et al. 2013). Physiologically,
ω-3 EPA and ω-6 Arachidonic Acid (AA) are both components of structural membrane
phospholipids, and they are also acting as the precursors for the production of eicosanoids
mediated by cyclooxygenase (COX) or lipoxygenase (LOX) enzymes. It is believed that
the anti-inflammatory molecules generated from EPA are less biologically active than the
pro-inflammatory AA-derivatives (Farooqui, Horrocks et al. 2007), which could partially
explain the tumor suppressor function of ω-3 FAs, considering that inflammation can
promote cancer development.
In addition to the lipids per se, some enzymes and regulatory proteins involved in
the de novo biosynthesis of FAs are important for cancer development as well. As
mentioned above, aerobic glycolysis and de novo FA biosynthesis are the two featured
events of neoplastic reprogramming cross-talking to each other in most cancer cells.
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Aerobic glycolysis produces large amounts of pyruvate, which enters mitochondria to
turn into citrate, and the latter is eventually transported into the cytosol and used for de
novo FA biosynthesis. Cytosolic citrate is first converted into acetyl-CoA by ATP citrate
lyase (ACLY) followed by carboxylation to malonyl-CoA catalyzed by acetyl-CoA
carboxylase (ACACA). The condensation of acetyl-CoA and malonyl-CoA to produce
the most common 16-carbon saturated FA palmitate is under the control of fatty acid
synthase (FASN). All three enzymes have been reported to be dramatically increased in
multiple types of cancer cells and the inhibitory treatments targeting these enzymes could
suppress proliferation in vitro and limit tumor growth in vivo (Hatzivassiliou, Zhao et al.
2005). In contrast to nontransformed murine hematopoietic cells, which are resistant to
apoptosis after ACLY is silenced, (Bauer, Hatzivassiliou et al. 2005), breast cancer cells
with silenced ACACA undergo apoptosis, but this can be rescued by supplementation of
palmitate in the medium (Chajes, Cambot et al. 2006). This observation undermines the
potential

for

ACACA

to

be

an

anticancer

drug

target.

Interestingly,

immunohistochemistry studies on different stages of breast cancer show that elevated
expression of ACACA and FASN already appears in DCIS and LCIS (Milgraum, Witters
et al. 1997), the earliest stages that can normally be clinically detected prior to the
massive cell proliferation, which suggests an active rather than passive involvement of
the activation of de novo FAs biosynthesis in early tumorigenesis. In agreement with this
postulate, the normal-appearing mammary gland tissues from the same patients showed
that a limited number of cells expressing ACACA and FASN are confined to lobules and
terminal ducts. Cancer usually initiates in terminal ducts (Milgraum, Witters et al. 1997),
where the mammary stem cells are also located (Esslimani-Sahla, Thezenas et al. 2007).
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Among the three enzymes, FASN attracted most attention because it catalyzes the last
key step of the FAs biosynthesis. In the early days, FASN was used as a predictor for the
recurrence of breast cancer, and the expression level of FASN was positively correlated
with poor prognosis and mortality (Kuhajda, Piantadosi et al. 1989). Ectopic expression
of FASN in nontransformed breast epithelial cell lines, MCF10A and HBL100,
significantly promoted cell proliferation via the activation of HER1/HER2 signaling
cascade (Vazquez-Martin, Colomer et al. 2008), but there seems to be a positive feedback
loop to promote mutual activation between HER1/HER2 and FASN. Indeed, on one
hand, it has been shown that FASN is a downstream component of HER1/HER2 (Jin,
Yuan et al. 2010; Li, Bu et al. 2012); on the other hand, immunohistological study of
breast lesions at different stages revealed that over-expression of FASN is already
detected in the nonproliferative benign breast disease lesions where HER2 level is yet to
increase (Milgraum, Witters et al. 1997). Given the facts that inhibition of FASN induces
cell cycle arrest and over-expression of FASN activates HER2 signaling pathway, FASN
behaves more like a “driver” role in cancer initiation. Yet, despite a clear positive
correlation, no evidence has been reported to support a causal effect of ACLY, ACACA,
and FASN in cancer initiation.
In parallel with the saturated FA (palmitate) pathway, cholesterol biogenesis
pathway (mevalonate) is also activated in the reprogrammed lipid metabolism in cancer
cells. The two pathways branch after citrate converts into acetyl-CoA. Mevalonate and
palmitate pathways are respectively regulated by two transcription factors, sterol
regulatory element-binding proteins (SREBP) 1 and 2, from the same gene family.
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SREBPs bind to sterol regulatory elements in the promoter regions of many genes coding
for the major enzymes participating in lipogenesis to mediate their transcriptions.
Currently

identified

signaling

pathways

upstream

of

SREBPs

including

Pi3K/AKT/mTOR and RAS/Raf/MEK/ERK again suggest a positive correlation of
SREBPs expression with cancer development.
Several recent publications may shed light on the connection between the
reprogrammed mevalonate pathway in cancer cells and the disruption of cell polarity.
The mutation of tumor suppressor gene TP53 is frequently seen in breast cancer. In most
cases, p53 mutation occurs in concert with the elevation of the mevalonate pathway.
Using a 3D cell culture system, the Prives group studied mammary gland morphogenesis
under the influence of p53. They showed that over-expressing mutant p53 in
nonmalignant MCF10A cells impaired lumen-like formation, and depletion of
endogenously mutated p53 in the metastatic breast cancer cell line MDA-MB-468 could
restore some architectural characteristics of in vivo mammary acini in 3D cell spheroids,
including lumen-like formation as well as the basolateral polarity indicated by
cytoskeleton actin and basally localized α6β4 integrins. Interestingly, the mevalonate
pathway is the major pathway down-regulated upon the depletion of mutant p53 in
reverted MDA-MB-468, and the reverted phenotype can be compromised by
supplementation of upstream metabolites in the culture medium (Freed-Pastor, Mizuno et
al. 2012).

Although it has been shown before that p53 suppresses SREBP as a

transcription factor (Yahagi, Shimano et al. 2003), this study is the first one to link the
mevalonate pathway to tissue polarity. Unfortunately, the study described here did not
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provide evidence regarding the reestablishment of apical polarity in the reverted cells as
no information on tight junctions was given.
In many cancerous diseases, sustained activation of the Hippo signaling pathway
promotes cell growth and proliferation, while it inhibits differentiation and apoptosis.
Upon activation, its downstream effectors YAP/TAZ relocate from the cytoplasm to the
cell nucleus where they function as transcriptional factors. Recent screening in breast
cancer cell line MDA-MB-231 uncovered that YAP/TAZ nuclear translocation can be
abolished by pharmaceutical inhibition of the mevalonate synthesis pathway suggesting a
regulatory role of this pathway on the Hippo pathway (Sorrentino, Ruggeri et al. 2014).
Surprisingly, numerous apical polarity-related proteins were identified to control the
cytoplasmic compartmentalization of YAP/TAZ. The relevant proteins include Crb 1-3,
Frmd6, NF2, Kibra, aPKC, PAR3, PAR6, PALS1, Scrib, Dlg, Lgl, AMOT, PEPN14,
Ajuba/LIMD1/WTIP, α-catenin, β-catenin, ZO-1, ZO-2, and E-cadherin (Yu and Guan
2013). Given that shutting down the mevalonate pathway can inhibit the Hippo pathway
by sequestering YAP/TAZ in the cytoplasm and also restore tissue architecture (at least
basolateral polarity (Freed-Pastor, Mizuno et al. 2012), an emerging hypothesis that the
mevalonate pathway activates the Hippo pathway by disrupting apical polarity might be
formulated.
1.4.

The nuclear bodies in cell nuclear organization

In addition to the polarity of the epithelium, another cellular architecture closely
reflecting various cellular activities is the cell nucleus. This notion is not new at all since
for decades, researchers have characterized several changes within the nuclear
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architecture concomitant with transition to malignancy and applied such changes as
classic criteria for cancer diagnosis, such as the increased nucleo-cytoplastic ratio and the
number of nucleoli. The nuclear architecture of the cell is generally defined as the spatial
and temporal arrangement of the nuclear bodies and chromatin within the nucleus.
Nuclear bodies are highly dynamic structures raised from the nucleation and interactions
among a large group of proteins/RNAs (Dundr and Misteli 2010). Due to the lack of lipid
membrane outside of the nuclear bodies, the components, proteins and RNAs, exchange
fast between the nuclear body and the surrounding environment. Yet overall, the
nucleation, the location, and the composing elements of several types of nuclear bodies
appear to remain stable. Thanks to the development of immunolabeling and imaging
techniques, a number of new nuclear bodies have been identified like 53BP1 body
involved in DNA repair (Panier and Boulton 2014) and polycomb body involved in
transcription control (Pirrotta and Li 2012). But even for the nuclear bodies identified
many years ago, important information is still elusive, especially regarding structure,
biogenesis and biological functions. Because many nuclear bodies are found temporally
associated with or close to specific chromosome loci, one of their functions is thought to
be protein storage for assigned chromosome activities under particular circumstances
(Dundr and Misteli 2010). In Table 1.4.1, I summarized current knowledge about the
“classic” nuclear bodies including nucleolus, Cajal body, splicing factor speckles,
Promyelocytic leukemia protein (PML) nuclear body, and perinucleolar body. The main
reference is the book “the nucleus” published by cold spring harb perspect biol: 2010.
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Table 1.4.1: Nuclear Bodies

Nuclear
bodies

Signature
components

Associated
chromosomal loci

Major
functions

RNAP I,
Fibrillarin, UBF,

Nucleolar organizing
regions (NORs)

Ribosomal RNA
transcription

Coilin, Fibrillarin,
survival motor
neuron protein,
SnRNAs,
SnoRNAs

Preferentially
associating with snRNA
genes upon their
transcriptional
activation; transient
association with
telomeres during S
phase; histone gene
clusters;
No DNA is found
within the nuclear
speckles, but they can
be preferentially
associating with highly
transcribed chromatin
loci.

snRNPs
modification;
telomere
synthesis;

Nucleolus

Cajal body (CB)

Nuclear
speckles/interchr
omatin granules

SC35, snRNPs,
RNAP II
components

PML, SUMO,
SP100, DAXX

Not associated with
chromosomes in general
conditions. Under stress
or DNA damage, PML
NBs can associate with
specific loci.

Pol II RNA
binding proteins
polypyrimidine
tract binding
protein, CUG-BP,
KSRP, Nucleolin;
small noncoding
RNAs transcribed
by Pol III
including Alu
RNA, hY RNA,
MRP RNA, RNase
P RNA, 7SL RNA

Localized at the
periphery of nucleolus,
but it is not clear if
associated with the
perinucleolar
heterochromatin.
Further evidence
strongly supports PNC
associating with
specific DNA locus
(sequence
nonidentified).

PML nuclear
bodies

Perinucleolar
compartments
(PNC)

Presumably
coordinating the
supply and/or
recycling of premRNA
processing and
transcription
factors.
Factory for
posttranslational
modifications,
including
acetylation,
sumoylation,
and
phosphorylation
of proteins.
Not clear but
hypothetically
involved in Pol
III transcription
regulation

Cancerrelated
events

referen
ce

Increased
number of active
nucleoli and
rRNA
transcription in
cancer cells
Telomerase
RNA colocalises
with CBs in
cancer cells

(Pederson
2011)

high number and
smaller of
speckles
compared to
phenotypically
normal cells

(Lelievre,
Weaver et
al. 1998;
Spector
and
Lamond
2011)

PML NBs are
disrupted in
PML-RARα
translation
causing acute
promyelocytic
leukemia

(Lalleman
dBreitenbac
h and de
The 2010)

Strongly
correlated with
malignancy in
solid tumor

(Pollock
and Huang
2010)

(Nizami,
Deryushev
a et al.
2010)
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For therapeutic purpose, an attractive research field is to understand the
biogenesis of nuclear bodies. In contrast to the assembly of cellular polarity that displays
a hierarchical order in the recruitment of various protein complexes, current evidence
support a stochastic self-organization model for the formation of specific nuclear bodies
(Dundr and Misteli 2010). This model highlights the equal importance of the essential
components of a nuclear body for its biogenesis. The model was proposed from the study
showing that the Cajal body can be generated de novo by nucleating a number of its
components including proteins and RNAs (Kaiser, Intine et al. 2008). Interestingly, the
formation of the PML body was also observed by over-expressing a component protein
of the PML nuclear body in the same study, suggesting that this model is not limited to
the Cajal body. The randomness of the initiator and the recruitment process is the core
concept of the stochastic self-organization model. Currently, the triggers in the first step
of nucleation remain unknown for most nuclear bodies.
1.5.

Chromatin organization and its biological functions in homeostasis

Our knowledge about chromatin organization in the cell nucleus is greatly
improved due to the development of high-throughput molecular biology techniques,
especially DNA next generation sequencing, chromatin conformation capture (3C)
(Dekker, Rippe et al. 2002), and thereafter 3C derived techniques. An amazing fact about
our genome is that the two-meter-long chromatin string has to be packed into a cell
nucleus with an average 10-micrometer in diameter. To efficiently respond to various
stimuli, the chromatin must be highly organized. Chromatin organization during the
interphase of cell cycle is characterized at different levels. The primary structure of
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chromatin is the well-known beads-on-a-string composed of histone octamers wrapped
by linear DNA. The secondary chromatin organization is the 30 nanometer fiber formed
by the interactions between neighbor nucleosomes of the primary structure. One of the
supportive pieces of evidence came from X-ray diffraction that unraveled zigzag
interaction among four nucleosomes with DNA strands (Schalch, Duda et al. 2005).
Beyond the 30-nm fiber are 100-nm fiber structures and even larger fibers that are part of
higher chromatin organization. These chromatin fibers are very likely organized into
loops anchored to the insoluble nuclear matrix through specific chromatin domains. This
proposed loop organization can be visualized protruding out of the nucleus with
application of a DNA dye after soluble nuclear proteins are removed (Roti Roti and
Wright 1987). DNA loops are essential structures to activate gene transcription by
mediating the interaction between nonadjacent enhancer and promoter (Ong and Corces
2011). In addition to these somewhat local interactions, interchromosomal and
intrachromosomal long-distance interactions are also executed by the loop structures. For
example, genes associated with a particular function are often activated simultaneously,
and frequent chromatin interactions among these genes can be detected by 3C although
some of these genes are located on different chromosomes, indicating the spatial
proximity for these DNA loops during transcription (Schoenfelder, Sexton et al. 2010;
Tanizawa, Iwasaki et al. 2010). The mechanism of loop generation is poorly understood,
but current evidence suggests a tripartite involvement of chromatin binding proteins,
specific chromatin regions and nuclear structural proteins. A group of proteins were
identified to engage in chromatin looping including CTCF, the cohesin/codensin
complex, mediator, SATB1, etc., among which, CTCF and the cohesin complex are

21
mostly studied. CTCF binds to the insulator, a DNA domain that is localized either
between the promoter and enhancer of a gene to block their communication or at the
boundaries of chromatin domains to demarcate the active and the repressive domains
(Cuddapah, Jothi et al. 2009; Van Bortle and Corces 2012). In many cases, the cohesin
complex and CTCF co-occupy the insulator domains to coordinate transcription
regulation (Wendt, Yoshida et al. 2008). The cohesin complex comprises SMC1, SMC3,
RAD21, and SA2 proteins that, together, form a ring structure. By tethering two binding
sites of cohesin on the same chromosome, the cohesin ring generates a chromatin loop
structure. The interchromosomal interaction will be engaged if the binding sites are on
two chromosomes. A fraction of cohesin binding on the genome is independent of CTCF.
Instead of repressing gene transcription, these cohesin complexes interact with mediator
at the promoter regions to initiate transcription (Kagey, Newman et al. 2010). Thus,
cohesin seems to be the key factor for chromatin looping per se but it is not responsible
for determining the activity of the target genes, which is likely controlled by cohesin
binding partners as well as the cohesin binding regions. Earlier studies have suggested
that the anchorage of the matrix attachment regions (MARs) on the nuclear matrix is the
structural basis for chromatin looping (Mirkovitch, Mirault et al. 1984; Heng, Goetze et
al. 2004). MARs are AT-rich domains, yet they have no consensus sequence and are
dispersed throughout the genome with a localization propensity at gene boundaries (Loc
and Stratling 1988; Levy-Wilson and Fortier 1989) or near regulatory elements (Cockerill
and Garrard 1986; Gasser and Laemmli 1986). Nuclear matrix is a putative dynamic
nuclear skeleton structure formed by insoluble nuclear proteins to support the whole
nuclear architecture and thus, nuclear activities. Multiple studies showing the association
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of CTCF/cohesin with the nuclear matrix as well as the overlap of their binding regions
with MARs (Nabirochkin, Ossokina et al. 1998; Hakimi, Bochar et al. 2002; Dunn, Zhao
et al. 2003; Yusufzai and Felsenfeld 2004) have indicated the indispensable role of
nuclear matrix proteins in chromatin looping. The binding of MARs onto the nuclear
matrix is gene activity and cell type-dependent, which reflects the dynamic nature of the
gene loci in 3D context. Consistent with this notion, particular cancer-related genes were
shown to reposition in a breast cell line upon acquisition of malignancy (Meaburn, Gudla
et al. 2009).
Chromatin self-organizes into globule-like structures within every one-megabase
interval in human cells (Dixon, Selvaraj et al. 2012; Nora, Lajoie et al. 2012), termed
topologically associating domains (TADs), which was also seen in the fruit fly (Sexton,
Yaffe et al. 2012) and budding yeast (Mizuguchi, Fudenberg et al. 2014) at different base
length intervals. Very interestingly, CTCF and cohesin were respectively described to
bind at the boundaries of TADs in human cells and budding yeast. Although only CTCF
was reported to bind about 15% of the boundaries of TADs in human cells so far (Nora,
Lajoie et al. 2012), it would not be surprising to see cohesin also bind to these regions at
even higher frequency given the results in yeast. These discoveries further reinforce the
essential role of CTCF and cohesin in global chromatin organization.

Beyond a

megabase scale at single chromosome level, it has been shown that multiple gene-rich
regions tend to cluster together both with fluorescence in situ hybridization (FISH)
(Shopland, Lynch et al. 2006) and 4C (Simonis, Klous et al. 2006) techniques. A general
agreement is that the gene-rich regions have more chance to localize within the interior of
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the nucleus compared to the gene-poor regions that are more often closed to the nuclear
periphery (Branco and Pombo 2006), which raised the assumption that the periphery of
the nucleus is less permissive for gene transcription. Indeed, this idea was reinforced by
the observation that the transcription was decreased when a reporter gene was tethered to
the peripheral nuclear lamina. This nuclear structure is composed of Lamin A/C and
Lamin B that, together, form a meshwork underneath the nuclear envelope (Dechat,
Pfleghaar et al. 2008). About 40% of the genome is associated with the nuclear lamina;
and these genomic regions are called lamina-associated chromatin domains (LADs)
(Guelen, Pagie et al. 2008). CTCF and cohesin are extensively occupying the chromatin
regions adjacent to the LADs, suggesting that a large amount of loops is attached to the
lamina.
Genome wide, chromosomes are arranged within chromosome territories. The
concept of chromosome territories was proposed by Boveri, T in 1909, who argued that,
as in mitosis, chromosome retains individuality during interphase by staying in their own
place. The model of chromosome territories was supported by a series studies, and finally
beautifully displayed in the human cell nucleus by Bolzer et al. using 3D FISH technique
combined with multicolor-labeled probes targeting different chromosomes (Bolzer, Kreth
et al. 2005). It demonstrated unequivocally that the chromatin is not randomly arranged
in the nucleus. It should be noted that although the majority of individual chromosome
parts stay in the chromosome territory, it is common to detect intermingling of different
chromosomes at the territory boundaries that are thought to be sites filled with most of
the types of nuclear bodies mentioned above, notably splicing factor speckles and

24
Polymerase II transcription factories (Deng, Melnik et al. 2013). Based on transcription
activity, nuclear chromatin is characterized into two states, euchromatin (active) and
heterochromatin (inactive). The geographic distribution of chromatin shares some
similarities among different cell types, for example, heterochromatin is accumulating at
the nuclear periphery and the nucleolar periphery upon cell differentiation. Nucleolusassociated chromatin domains (NADs) also have been identified (Nemeth, Conesa et al.
2010); strikingly, they are extensively overlapping with LADs. It is possible that a
portion of heterochromatin can randomly associate to the nucleolus or the lamina. If this
is the case, the interphase chromatin may display a divergent organization while the cells
possess identical functions.
Chromatin organization determines cell function and identity. Maintaining a
particular chromatin organization is as important as specific transcription factors in
producing induced pluripotent stem cells (Yu, Vodyanik et al. 2007). Even if the overexpressed transcription factors displayed the same binding profile on specific promoter
regions, the cell could not be reprogrammed into pluripotent stem cell without chromatin
forming the correct loop structure (Wei, Gao et al. 2013; Zhang, Jiao et al. 2013). Altered
chromatin organization is one of the remarkable features of cancer cells (Suva, Riggi et
al. 2013). Genome-wide sequencing studies based on 3284 tumors have identified a
quarter of a million genetic mutations spread on 20,000 protein-coding genes, but only
about 125 mutated genes were considered to play the “driver role” in cancer initiation,
among which, 20% functions in chromatin regulation (Vogelstein, Papadopoulos et al.
2013). These “cancer-driving” nuclear architectural organizers include enzymes for
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epigenetic modifications and chromatin binding proteins, which accordingly determine
the degree of local chromatin compaction and 3D chromatin topology, both known to
profoundly affect gene transcription activity (Dawson and Kouzarides 2012) as well as
genome integrity. To this end, identification and characterization of such architectural
proteins will fundamentally improve our knowledge of cancer and thus, its prevention.
1.6. The function of NuMA in chromatin organization control
The nuclear mitotic apparatus protein (NuMA) was first recognized for its well
defined role in stabilizing mitotic spindle during cell division (Lydersen and Pettijohn
1980), which makes NuMA an essential protein for cell proliferation and the
development of organisms. However, beyond mitosis, NuMA is intensively expressed in
the interphase nucleus in multiple cell types (Abad, Lewis et al. 2007), including the
neuron cells, years after differentiation and quiescence have occured (Silk, Holland et al.
2009; Radulescu and Cleveland 2010), which raised the interesting postulate that NuMA
must perform functions in the nucleus aside from mitosis. NuMA is a large protein of
about 240 kilo Dalton with a central coiled-coil domain. The coiled-coil domain provides
the structural basis for protein self-polymerization, which was exemplified for many
other proteins and protein complexes, like Lamin family members and SMC family
members in cohesin/condensin (Herrmann and Aebi 2004; Poon and Mekhail 2011).
Indeed, in Hela cells with NuMA transiently over-expressed, hexagon oligomers were
formed by the self-organization of NuMA and a large amount of these oligomers
arranged into a lattice-like structure filling the nucleus and resistant to detergent
extraction (Gueth-Hallonet, Wang et al. 1998; Harborth, Wang et al. 1999). Due to the
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insolubility of a fraction of NuMA proteins and the interaction of NuMA with MARs, it
has been proposed that NuMA is a nuclear matrix protein (Luderus, den Blaauwen et al.
1994; Nickerson 2001). Several NuMA interacting partners in the nucleus have been
reported including GAS41 (Harborth, Weber et al. 2000), NOCA6 (Ko and Chin 2003),
and PIM1 (Bhattacharya, Wang et al. 2002), but their role associated with NuMA
remains unknown.
Our laboratory has been long focusing on the nuclear function of NuMA after first
observing a remarkable redistribution of NuMA in the cell nucleus upon differentiation in
non-neoplastic mammary epithelial HMT-3522 S1 cells in 3D cell culture (Lelièvre,
Weaver et al. 1998), which led to the assumption that the rearrangement of NuMA is
concomitant with nuclear reorganization and tissue architecture. Consistent with this idea,
differentially distributed NuMA was observed between non-neoplastic S1 cells and S1derived invasive T4-2 cancer cells (Knowles, Sudar et al. 2006; Chandramouly, Abad et
al. 2007), the S1 cells that were seeded on different extracellular matrix materials, as well
as the S1 cells exposed to radiation (Vidi, Chandramouly et al. 2012). In addition, NuMA
accumulates at DNA damage spots within 30 minutes (Vidi, Liu et al. 2014). All these
subtle redistributions of NuMA corresponding to different environmental stimuli
suggested that, at least, a subset of NuMA is dynamic and sensitive to
microenvironmental cues.
As discussed earlier, the nuclear architecture comprises nuclear bodies and chromatin
organized in a spatial and temporal manner. Interestingly, NuMA colocalization with
splicing factors (Lelièvre, Weaver et al. 1998) and association with chromatin (Abad,
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Lewis et al. 2007) were both observed in the breast epithelial model. Hence, NuMA
possibly plays a global nuclear architectural role by regulating nuclear bodies and
chromatin organization together. The involvement of NuMA in higher order chromatin
organization, as witnessed by the location of heterochromatin and euchromatin, was
established (Abad, Lewis et al. 2007), but the underlying mechanism is still missing.
Studies from our group have identified ISWI SNF2h ATPase as one of NuMA’s binding
partners (Vidi, Liu et al. 2014), pointing out a reasonable direction for further analysis.
given the fact that SNF2h participates in several chromatin remodeling complexes
(CRCs) (Dirscherl and Krebs 2004) involved in different cellular functions. Following
this clue, SNF2h-containing CRCs were assessed for their potential interactions with
NuMA, and the B-WICH complex functioning in rDNA transcription was identified
(Jayaraman, S. Ph.D. Thesis, 2014). Combined with several other pieces of evidence
from our previous work indicating that NuMA might function in the nucleolus (the
detailed discussion can be found in Chapter 2), I proposed my hypothesis that NuMA
might control the architecture of the cell nucleolus. Consequently, the nucleolar
architecture and function is introduced in the next section.
1.7. Cell Nucleolus
“The nucleolus probably should not be considered a relatively simple organelle
with a single function, comparable to a machine tool turning out a particular part of an
automobile. It is not just ‘the organelle where the cell manufactures ribosomes.’ It is
rather a structure through which materials of several different kinds are flowing,
comparable more to a whole production line than to a single machine tool.”
&RQUDG+DO:DGGLQJWRQ
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The cell nucleolus is the most prominent nuclear body because of its high
visibility, even under the light microscope, and its documentation that can be tracked
down to the seventeenth century, decades earlier than other nuclear bodies. In nucleolus
research history, two breakthrough discoveries probably are the identification of the
nucleolar organizing region (NOR) as a fragment of the chromosome where the nucleolus
forms, and the demonstration of the nucleolus function in ribosome biogenesis. The
generation of nucleoli taking place on NORs was first reported by Heitz, E in 1931, and
the link between ribosome biogenesis and nucleolus was established by Donald Brown
and John Gurdon in 1964 (Brown and Gurdon 1964). Immediately after the discovery of
the nucleolus function in ribosome biogenesis, Conrad Hal Waddington made the
comment that I cited at the beginning of this section. I came across these remarks in a
memorabilia-like review article (Pederson 2011) and I am surprised too, as much as the
author of the article, by the accuracy of Waddington’s perspective half a century ago, as
the advances in research on the nucleolus are showing every word of the statement to be
true.
Electron microscopy analysis of the nucleolus in mammals revealed a tripartite
structure including the fibrillar center (FC), the dense fibrillar component (DFC), and the
granular component (GC). With some disagreement on the functions of these individual
regions, a more commonly accepted opinion is that ribosome DNA transcription occurs
in DFC as well as at the border of FC and DFC, while GC is the place for ribosomal RNA
maturation. Both RNA Polymerase I (Pol I) and rDNA were found in FC, but they are
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thought to lack transcription ability. Once the transcription is activated, Pol I-bound
rDNA relocates to DFC (Raska, Shaw et al. 2006). Permeability and protein density
analysis of the nucleolus in Xenopus oocyte showed a higher density of the dense fibrillar
component, indicating that more proteins are present in the DFC compared to the
granular component (Handwerger, Cordero et al. 2005). Permeability assay showed that
GC is a sponge-like structure filled with two types of particles, protein-rich and nucleic
acid-rich – likely reflecting its functions in rRNA processing and ribosome assembly.
Outside

the

nucleolus

is

a

heterochromatin

shell.

The

perinucleolar

heterochromatin in human HeLa cervix carcinoma cells (Nemeth, Conesa et al. 2010) and
HT1080 fibrosarcoma cells (van Koningsbruggen, Gierlinski et al. 2010) has been
isolated and sequenced. The identified chromosomal regions mainly include “satellite
repeats, members of the zinc-finger, olfactory receptor defensin, immunoglobulin
protein-coding gene families, transcriptionally active 5S rRNA genes and tRNA genes”
(Nemeth and Langst 2011) accounting for 4% of the whole genome (unsequenced rDNAbearing short arms are not included). In addition, a fraction of centromeres (Pluta,
Mackay et al. 1995) and telomeres were also reported as the constituents of the
perinucleolar heterochromatin, probably due to their physical proximity to NORs on the
acrocentric chromosomes. In every sense, the perinucleolus is a subnuclear site
characterized as transcription-repressive environment. Interestingly, this “transcriptionunfriendly” site is found to transiently associate with many specific nuclear components
in unusually high frequency at different cell stages, which implies some potential
biological functions still to be elucidated. For example, large heterochromatin bulks
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relocating to the perinucleolus is a signature of mammary epithelial cell differentiation
(Lelievre 2009). Chromosome Xinactive remains silenced through its contact with
perinucleolar heterochromatin in S phase (Zhang, Huynh et al. 2007). Some nuclear
bodies, like splicing factor speckles (Lelièvre, Weaver et al. 1998), Cajal body, PML, and
the perinucleolar compartment, were reported to be close or in touch with the periphery
of the nucleolus, yet the functions of these contacts are elusive. With respect to the
chromatin relocation to the perinucleolus, several chromatin binding proteins are thought
to be important for the procedure, like CENPC1 (Wong, Brettingham-Moore et al. 2007)
and CTCF (Yusufzai, Tagami et al. 2004).
Although the nucleolus is considered as one of the nuclear bodies, it possesses a
fundamental difference compared to others, which is that the assembly of the nucleolus
completely depends on the specific chromosomal domains NORs. NORs are tandem
rDNA arrays arranged in head-to-tail coding for ribosomal RNAs. The copy number of
rDNA and NORs varies largely among species. The human genome contains about 400
copies of rDNA distributed over five pairs of NORs located between the satellite
repetitive elements and the pericentromeric region on the short arms of acrocentric
chromosomes 13, 14, 15, 21, and 22. Due to high repetition, DNA sequences of the short
arms of these chromosomes are still not deciphered (Shaw and Mckeown 2011). The
large copy number of rDNA is believed to meet the requirements of ribosome biogenesis
for protein synthesis in proliferating cells. Indeed, ribosomal RNA accounts for 60% and
35% of total RNA synthesis respectively in yeast and dividing mammalian cells (Moss,
Langlois et al. 2007). Yet, genetically modified yeast strain with 20-copy rDNAs showed
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no difference regarding the rRNA level compared to the strain with 110 copies except for
increased sensitivity to DNA damage. Thus, the unusually large copy number of rDNA in
the genome, especially the subset kept silent, is hypothesized to protect genome integrity
rather than being used for ribosome biogenesis (Ide, Miyazaki et al. 2010). In human
cells, each single copy of rDNA encodes a 45S pre-rRNA precursor that contains, in
order, 18S, 5.8S, and 28S rRNA coding regions. There are two external transcribed
spacers (ETS) at 5’ end before 18S and 3’ end after 28S in the 45S pre-rRNA. In
addition, the 5.8S rRNA coding region is flanked by two internal transcribed spacers
(ITS) in the middle of 18S and 28S. Both ETSs and ITSs are cleaved from 45S prerRNA during rRNA processing to eventually generate 18S, 5.8S, and 28S rRNAs.
Another rRNA 5S is transcribed from another genomic region by RNA polymerease III.
Individual rDNAs are separated by the intergenic spacer (IGS). Again, IGS sequences
and lengths are highly divergent among different species, from several kb in yeast to
30kb in human. IGS in mouse contains several rDNA regulatory elements including gene
promoter, spacer promoter, and gene terminator distributed at both ends of one IGS. The
schematic diagram of mouse rDNA and IGS is shown below.

Figure 1.7.1

Diagram of mouse rDNA and IGS. The external transcribed regions are

represented by purple frames, the internal transcribed regions are represented by orange
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frames, coding regions are represented by white hollow frames, and IGS is the blue line
located between two rDNA genes. The locations of some regulatory elements are labeled
on the top of the rDNA gene. This figure is modified based on the published scheme
(McStay and Grummt 2008).
The ribosomal DNA promoter is located -200bp to +50bp relative to the
transcription start site (TSS) at 3’ end of IGS, and the terminator region is located at the
end of rDNA indicated by the red bars. This region usually contains repetitive terminator
elements numbered as T1-T10. Tsp is the spacer promoter located at about -2 kb upstream
of TSS and its corresponding terminator T0 is immediately upstream of TSS. Tsp drives
the transcription of intergenic spacer RNA, which mediates rDNA transcription
repression.

Tandem repeats 1 and 2 contain large amounts of single repeats and

transposable elements, yet their functions are still unclear (Sylvester JE 2004).
Furthermore, it should be noted that no alignment study of IGS between mouse and
human has been reported so far; therefore, it is not clear whether human IGS contains all
the regulatory elements at the corresponding positions.
The mechanism of nucleolus assembly has attracted much interest since the
number of the nucleoli and the nucleolar morphology are the most prominent markers of
the nuclear architecture correlated with cell proliferation activity. It has been noticed for
a long time that the disassembly and reassembly of the nucleolus are controlled by the
cell cycle. The Nucleolus starts to dissemble in early prophase, during which, CDK1cyclin B plays an important role by phosphorylating B23. The phophorylation results in
the dissociation of B23 from rRNA. B23, as well as other rRNA processing components,
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is released from the nucleolus and distributed on the surface of condensed chromosomes
(Okuwaki, Tsujimoto et al. 2002; Negi and Olson 2006). But the upstream binding factor
(UBF) and particular Pol I subunits still remains in NORs through the cell cycle. The
nucleolus reassembly occurs in telophase, with all the dissociated components regathering on the NORs and the reactivation of transcription as well as processing of
rRNA. Transcriptional activity of rDNA was once considered as the trigger for nucleolus
restoration; however, the study of pseudo-NORs demonstrated that partial formation of
the nucleolus can still happen without transcriptional activity (Prieto and McStay 2008).
Pseudo-NORs are tandem arrays of a DNA sequence obtained from Xenopus rDNA and
incorporated into human chromosomes. They only contain repeated enhancer elements
and lack the rRNA coding region, hence it is transcription incapable. By using this
model, the authors unarguably showed partial formation of the nucleoli around those
pseudo-NORs with components similar to FC. UBF binding to the enhancer elements
determines the initiation of nucleolar reestablishment and other procedures are likely
following a self-organization mechanism. Interestingly, the restoration of nucleoli in new
daughter cells only takes place on the NORs that are actively transcribed in the mother
cells (Roussel, Andre et al. 1996). This observation strongly suggested the inheritance of
rDNA chromatin organization between cell generations. Epigenetic modifications on
DNA and nucleosomes are likely responsible for the inherited rDNA organization in cells
from one generation to next.
In early years, scientists had noticed the structural difference between active
rDNAs and silent rDNAs on “miller spread” (Christmas tree) in yeast under the electron
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microscope, which is that active rDNAs displayed the “Christmas tree” structures with
knobs of ribonucleoproteins on the branches while silent rDNAs showed no branches at
all (Miller and Beatty 1969). DAPI staining analysis of metaphase chromosomes revealed
gaps in active NOR regions, indicating locally decondensed chromatin structure
compared to the intense staining on silent NORs that is not distinguishable from
heterochromatin. Psoralen intercalates in DNA that is not protected by nucleosomes.
Cross-linking assay performed on murine Friend cells showed that psoralen specifically
induced DNA cross-linking in active NORs but not in silent NORs, which led the author
to conclude that nucleosomes are gone from active rDNAs but still present on IGS and
the inactive NORs (Conconi, Widmer et al. 1989). Despite validation of this observation
in yeast (Merz, Hondele et al. 2008) and human cells (Zentner, Saiakhova et al. 2011),
other studies have found the presence of histones on the active rDNA (Jones, Kawauchi
et al. 2007). This discrepancy has not been well explained so far; it is possibly caused by
the existence of other types of chromatin-binding histones, in addition to nucleosomes in
rDNAs (Prior, Cantor et al. 1983), or by differences in sensitivity and threshold setup
among different techniques. Nevertheless, DNA methylation was found to be enriched on
the condensed inactive NORs, which indicates an important role of methylation in the
maintenance of rDNA silencing (Stancheva, Lucchini et al. 1997). Ribosomal DNA
methylation usually occurs on CpGs in the promoter region and it is mediated by DNA
methyltransferases DNMT1, DNMT3a, and DNMT3b. Very interestingly, only
methylated rDNA chromatin (with the presence of nucleosomes), but not naked rDNA
can be repressed in vitro, which suggests the importance of chromatin conformation
under epigenetically controlled rDNA silencing (Santoro and Grummt 2001). Methylated
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CpG at -133 bp impairs UBF binding to the promoter in mouse cells and consequently
prevents rDNA transcription. A link between hypomethylation of rDNA promoter and
elevated rRNA transcription has been reported in several cancer types (Powell, Mutch et
al. 2002; Ghoshal, Majumder et al. 2004), and a causal relationship is thus proposed.
However, recent investigations in human prostate cancer tissues (Uemura, Zheng et al.
2012) and breast cancer tissues (Bacalini, Pacilli et al. 2014) either failed to recapitulate a
significant change of methylation level in rDNA promoter or revealed hypermethylation
of promoter in tumor tissues compared to normal tissues although rRNA level is
increased.

Even more complex, decreased rRNA level was observed upon the

reactivation of former silent rDNA, which was mediated by knocking out
methyltransferases or applying a methyltransferase inhibitor, like 5-Azacytidine (5-Aza)
(Chen, Comai et al. 1998; Gagnon-Kugler, Langlois et al. 2009). All current evidence
concurs to a surprising conclusion that the elevation of rDNA transcription in cancer
tissue is not necessarily correlated with rDNA methylation level, or with the number of
active NORs. A methylation-independent control of rRNA transcription and a globalmonitoring system might exist in parallel to the canonical methylation-dependent
mechanism. Depletion of UBF in human NIH3T3 cells did induce silencing of a subset of
rDNA and condensation without significant changes in methylation levels after many cell
generations (Sanij, Poortinga et al. 2008). It will be important to recapture this
phenomenon under physiological conditions.
Another layer of epigenetic control of rDNA activities is posttranslational histone
modifications. In fact, rDNA methylation and histone modifications are interdependent.
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Study in Arabidopsis showed that rDNA promoter demethylation mediated by 5-Aza led
to repressive histone marks transiting into active marks. Similarly, blocking the function
of histone deacetylase automatically resulted in the decrease of methylation level on
rDNA (Earley, Lawrence et al. 2006). The interdependent transition of these epigenetic
marks is caused by the interactions and mutual recruitments among distinct epigenetic
modification proteins. Novel histone markers specific to rDNA are not reported so far,
which suggests a similar epigenetic mechanism for the control of rDNA activities
compared to the rest of chromatin.
The recruitment of chromatin remodeling complexes to rDNA determines future
epigenetic state and rDNA structure. For example, rDNA silencing and condensation are
mainly mediated by nucleolar remodeling complex (NoRC), which contains TIP5 (TTF1interacting protein 5) and an ATPase protein SNF2h (Strohner, Nemeth et al. 2001).
TIP5 binds rDNA promoter and recruits HDAC1 (histone deacetylase 1) (Zhou, Santoro
et al. 2002) as well as DNMT1/DNMT3B (DNA methyltransferase) (Zhou and Grummt
2005) to accomplish epigenetic modifications. Depletion of TIP5 not only abolishes
rDNA silencing but also impairs the organization of perinucleolar heterochromatin
including centric and pericentic repeats (Guetg, Lienemann et al. 2010).

SNF2h

functions in sliding the nucleosomes on the chromatin to increase the accessibility for
other proteins. Environmental energy deprivation induced rDNA silencing is mediated
by eNoSC containing nucleomethylin, the NAD+ -- dependent deacetylase SIRT1, and
H3K9 methyltransferase SUV39H1. Coexistence of NoRC and eNoSC complexes that
both mediate rDNA silencing suggests distinct rDNA silencing mechanisms in cells
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responsive to different stimuli. The activation of rDNA transcription is also mediated by
different protein complexes. For instance, the ERCC6 (excision repair crosscomplementation group 6) / Pol I / histone methyltransferase G9a complex competitively
binds rDNA promoter with NoRC (Yuan, Feng et al. 2007). Another complex B-WICH
also interacts with Pol I to mediate rDNA transcription. The B-WICH complex contains
NM1 (actin and nuclear myosin 1c) / WSTF / SNF2h and NM1 plays a central role in
stabilizing SNF2h and actin on rDNA in addition to recruiting HAT (histone
acetyltransferase) (Sarshad, Sadeghifar et al. 2013). Interestingly, SNF2h was found in
both rDNA activation complex and silencing complex, which implicates its important but
not selective role in altering local rDNA structure.
A large number of active rDNA repeats neighboring the transcription-repressive
perinucleolar heterochromatin in the cell nucleolus must require a highly organized
chromatin arrangement to avoid interference between euchromatin and heterochromatin.
Active rDNAs are located inside the nucleolus while silent rDNA arrays are at the
periphery, closed to the perinucleolar heterochromatin (Santoro 2011). This is consistent
with previous observation that rDNAs within the nucleolus relocate to the nucleolar
periphery upon treatment with actinomycin D, a drug that inhibits Pol I at low
concentration. The localization of the proximal regions and the distal regions (relative to
centromere) flanking NORs was also studied in the interphase nucleolus recently and the
result clearly showed that the flanking regions are located at the periphery of the
nucleolus with active decondensed rDNAs stretching into the center (Floutsakou,
Agrawal et al. 2013). Several rDNA looping models have been proposed based on the
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involvement of different proteins. In the mouse, the terminator sequence motif (T1-T10,
see Figure 1.7.1) is recognized by the transcription termination factor TTF-I. In addition
to binding to T1-T10 to terminate rDNA transcription, TTF-I also binds to spacer
terminator T0 located upstream of the TTS functioning in transcription initiation (Langst,
Blank et al. 1997; Langst, Becker et al. 1998). By using 3C technique, Langst et al.
showed high frequency of interaction between the spacer terminator (T0 region) and the
gene terminator (T1-T10 region) indicating that a loop structure is created by tethering
these two sites. The authors further showed that TTF-I mediates the loop by binding on
these sites (Nemeth, Guibert et al. 2008). Later on, the same group demonstrated that
more terminator elements significantly improved transcription efficacy compared to less
terminator elements within a single chromatin loop (Diermeier, Nemeth et al. 2013). Yet,
neither study addressed the role of IGS in this TTF-I mediated rDNA loops model. In
contrast, based on the direct involvement of c-MYC in rDNA transcription (Shiue,
Berkson et al. 2009), Shiue et al. identified potential matrix attachment regions (MARs)
in IGS and proposed a c-MYC mediated r-chromatin looping model in human and rat
(Shiue, Nematollahi-Mahani et al. 2014). This model addressed the binding between
MYC and IGS upon transcription activation, which allows the transcribed regions to
remain in the loops. Because MYC is not characterized as a nuclear matrix component,
somehow it has to bridge the association of IGS and the nuclear matrix. The study did not
clarify whether MYC attaches to the nucleolar matrix, thus it is not clear how the loops
are anchored. In another study of the MARs in IGS, Zillner et al. showed that TIP5
directly binds MARs through its TAM (TIP5/ARBP/MBD) domain as a component of
the nuclear matrix (Zillner, Filarsky et al. 2013). This work proposed a model for the
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organization of a large number of rDNAs under a transcription permissive environment.
Although the cohesin complex is well known for its loop-generating role genome wide
and a large body of evidence has confirmed cohesin in rDNA transcription and nucleolar
organization control, its potential influence on rDNA looping architecture is not reported.
The coordination of rapid cell division and increased nucleolar activities has been
reported in many, if not all, types of cancers.

On one hand, the accelerated cell

proliferation of cancer requires more ribosome production to support increased demands
on protein synthesis. This goal can be achieved by over-expressing a variety of oncogenic
proteins.

Many oncoproteins

simultaneously function

in

up-regulating rDNA

transcription and promoting cell division, for example, c-MYC directly binds rDNA
promoter E-box to stimulate rDNA transcription (Arabi, Wu et al. 2005; Grandori,
Gomez-Roman et al. 2005), in addition to binding other cell cycle regulatory genes
(Bretones, Delgado et al. 2014). Activation of AKT can phosphorylate casein kinase IIα
(CK2α) and CK2α further phosphorylates Pol I binding partner TIF-IA to initiate rDNA
transcription (Nguyen le and Mitchell 2013). On the other hand, a sufficient number of
ribosomes is also thought to be the prerequisite for cell cycle progression from G1 to S
phase (Pederson 2011). The underlying mechanism is that the cell mass must reach a
certain level prior to the division and this parameter is examined at check point in G1
phase. The cell mass is mainly characterized by the protein amount in a cell, which is
further determined by the amount of ribosomes; ribosome biosynthesis is therefore
determining cell cycle rate. Indeed, the arrest of cell proliferation induced by impaired
ribosome biosynthesis was reported as early as when the nucleolar function was first
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described in 1964 (Brown and Gurdon 1964) and thereafter. The nucleolus as the place
for rDNA transcription, rRNA processing, ribosome assembly and exporting, is highly
sensitive to a variety of external or internal deleterious stimuli that hinder ribosome
production, via a cellular reaction termed nucleolar stress. Not surprisingly, any
functional disruption of the nucleolus may lead to cell cycle arrest due to ribosome
deficiency.
Interestingly, compelling evidence has also unveiled a direct role of the nucleolus
in cell cycle control beyond ribosome production. Proteomic analyses performed on
purified nucleoli of human HeLa cells have identified over 700 proteins associated with
the nucleolus (Andersen, Lyon et al. 2002; Andersen, Lam et al. 2005). This is a large
number of proteins identified in a single nuclear body and surprisingly, a large portion of
them are irrelevant to ribosome biogenesis, which strongly suggests a multifunctional
role of the nucleolus in addition to ribosome biogenesis. Among those 700 proteins, 25
are functionally categorized as cell cycle regulators, yet few studies have been conducted
to elucidate their roles in the nucleolus so far. More direct evidence came from the study
of P53 activation mediated by nucleolar stress. The expression of P53 remains very low
in cells under normal condition; however, the level elevates rapidly upon nucleolar stress.
Many ribosome subunit components including RPL5, RPL11, RPL23, PRL26, RPL37,
RPS3, RPS7, RPS14, RPS15, RPS20, RPS25, RPS26, RPS27, RPS27L (Golomb,
Volarevic et al. 2014), 5S RNA (Sloan, Bohnsack et al. 2013), and nucleolus-localized
protein Arf (Weber, Taylor et al. 1999) can be released from the nucleolus upon nucleolar
stress and directly bind P53 E3 ubiquitin ligase MDM2 to block P53 degradation. The
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increased P53 subsequently leads to cell cycle arrest. Since so many nucleolar
components regulate P53 in a similar manner, there is no doubt about the dual-role that
the nucleolus plays, ribosome biogenesis and stress sensor, and both roles are tightly
linked to the cell cycle.
In this thesis work, I am focusing on two aspects of cellular architecture, polarity
and nucleolar organization that are essential for cellular homeostasis to further decipher
their role in cancer. My overarching hypothesis is that the function of both of these
structures can be further deciphered by studying single proteins that act as nodes for the
control of cellular homeostasis. In the next chapter I will present work related to the
understanding of the role of the nuclear structural protein NuMA, previously involved in
differentiation, response to DNA damage, apoptosis and cell quiescence, in the
architectural and functional control of the nucleolus. In another chapter, I will discuss the
involvement of CDS1, a protein associated with Pi3K-AKT pathway regulating cell
growth and proliferation, in the control of tissue polarity and invasive growth.
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CHAPTER 2: NuMA INFLUENCES NUCLEOLAR ARCHITECTURE AND
FUNCTION

2.1. Introduction
Nuclear architecture refers to the spatial and temporal organization of the
chromatin and the nuclear bodies. NuMA, an organizer of higher order chromatin (Abad,
Lewis et al. 2007) was also found to overlap with nuclear bodies like splicing speckles
(Lelièvre, Weaver et al. 1998) and Cajal bodies (Gribbon, Dahm et al. 2002), suggesting
a potential role for NuMA in the global control of nuclear architecture. The cell nucleolus
is the nuclear body for rRNA production, processing, and ribosome assembly, which
requires a complex organization. The nucleolus contains rDNA and nucleolar proteins
and it is surrounded by a heterochromatin shell (Nemeth, Conesa et al. 2010).
Heterochromatin domains such as centromere and pericentromere (Nemeth, Conesa et al.
2010), specific proteins such as CTCF and Tin2 (Yusufzai and Felsenfeld 2004;
Kaminker, Plachot et al. 2005), and particular nuclear bodies such as the Cajal body and
splicing speckles (Lelievre, Weaver et al. 1998) were observed to be specifically
associated with the nucleolus with an unusually high frequency during cell
differentiation, suggesting the importance of the nucleolus-related organization in
homeostasis and differentiation mediated cell quiescence.

43
Mounting evidence suggests a link between NuMA and the nucleolus. Formerly,
claims were that NuMA was absent from the nucleolus as observed by
immunofluorescence microscopy (Gueth-Hallonet, Wang et al. 1998; Zeng 2000), yet a
high-sensitivity nucleolar proteomic study revealed an association between NuMA and
the nucleolus, which is consistent with our observation using soft X-ray electron
microscopy (Lelièvre, unpublished data) as well as electron microscopy analysis of the
nucleolus (Jayaraman, S. Ph.D. Thesis, 2014). This discrepancy can be logically
explained by the fact that DNA density is extremely low in the nucleolar region, where it
usually appears as a black hole when the nucleus is stained with DNA dyes, given the
fact that NuMA is a chromatin-associated protein (Abad, Lewis et al. 2007). The BWICH complex containing SNF2h, WSTF, and NM1 was immunoprecipitated with
NuMA (Jayaraman, S. Ph.D. Thesis, 2014), suggesting that NuMA might be involved in
ribosomal DNA transcription control, considering the well-known function of the BWICH complex in rDNA activation (Sarshad, Sadeghifar et al. 2013). The enrichment of
NuMA was observed at the perinucleolus to coincide with cell differentiation (Abad,
Lewis et al. 2007) and NuMA also accumulated at the periphery of nucleolus in response
to RNA Polymerase I inhibition (Abad, P. M.S. Thesis, 2003). These results raised the
possibility for NuMA to be involved in rDNA transcription control through the regulation
of chromatin organization. Thus, in the major part of my thesis, I have studied the
potential role of NuMA in the regulation of nucleolar architecture and rDNA
transcription. To elucidate the underlying mechanism of how NuMA might influence
chromatin structure, I hypothesized that NuMA and specific chromatin-associated
complexes co-organize DNA structure. To this end, the interaction between NuMA and
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the cohesin complex and the effect of NuMA on chromatin looping were specifically
studied.
Our laboratory previously reported that in multicellular spheroids produced in 3D
culture and displaying impaired apical polarity, inducing NuMA redistribution within
nuclei pushes quiescent cells into the cell cycle (Chandramouly, Abad et al. 2007). This
is an interesting observation since it directly links changes in nuclear architecture to its
potential biological consequence - the loss of cell quiescence.

Furthermore, the

redistribution of epigenetic marks at the perinucleolus was observed when the function of
endogenous NuMA was impaired by over-expressing its C-terminal peptide in nonneoplastic breast epithelial S1 cells (Abad, Lewis et al. 2007), which gave rise to the
hypothesis that the integrity of the nucleolar architecture maintained by a functional
NuMA is necessary for cell quiescence. Thus, among research efforts I also assessed the
influence of NuMA on the cell cycle by assessing Ki67 cell cycle marker given its
potential involvement in nucleolar functions and the tight correlation between nucleolus
and cell cycle.
2.2. Materials and methods
2.2.1. Cell culture
Non-neoplastic S1 HMT-3522 cells (human mammary epithelial cells (HMEC))
(Briand, Petersen et al. 1987) between passages 52 and 60, were plated at 1.75 x 106
cells/cm2 and maintained for 10 days for propagation as monolayers in chemically
defined H14 medium (Blaschke et al., 1994; Plachot and Lelièvre, 2004) [DMEM/F12
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(Invitrogen Corporation), supplemented with 0.15 IU/ml prolactin (Sigma-Aldrich), 250
ng/ml insulin (Sigma-Aldrich), 2.6 ng/ml sodium selenite (BD Biosciences), 2.67x10-5
ng/ml β-estradiol (Sigma-Aldrich), 0.5 ng/ml hydrocortisone (Sigma-Aldrich), 10 μg/ml
transferrin (Sigma-Aldrich)], including 5 μg/ml epidermal growth factor (EGF; BD
Biosciences). Malignant T4-2 HMT-3522 HMECs (Briand et al., 1996) between passages
2 and 20 were plated at 8.75 x 105 cells/cm2 and maintained for 6 days in twodimensional (2D) culture in H14 medium lacking EGF (H14-EGF). Human mammary
epithelial MCF7 cancer cells (ATCC) of metastatic origin were plated at 8.75 x 105
cells/cm2 and maintained for 4-6 days in 2D culture in DMEM medium with 10% fetal
bovine serum.
Three-dimensional (3D) cell culture of S1 cells was used in some studies for its
merit of mimicking mammary epithelial differentiation; the detailed procedure was
followed as described previously (Plachot and Lelievre 2004). Compared to the
traditional monolayer (2D) cell culture method, in which cells are proliferating on a
plastic surface, cells in 3D cultures are surrounded by extracellular matrix-enriched
medium (Plachot and Lelievre 2004).

To recapitulate the formation of polarized

glandular structures (acini), S1 cells were cultured in the presence of exogenous
extracellular matrix (ECM) enriched in basement membrane components (Matrigel™,
BD Biosciences). Briefly, S1 cells (35,000 cells/cm2) were plated on 41 µl/cm2 matrigelcoated surfaces and cultured in H14 medium containing 5% Matrigel™. Cells were
induced to exit the cell cycle upon incubation in H14 medium without EGF for 48 h after
day 8 of culture. Acinar morphogenesis, characterized by the formation of a single layer
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of epithelial cells surrounding a lumen and delineated by an endogenous basement
membrane, was routinely observed by days 9–10. Medium was renewed every 2-3 days.
All cells were cultured at 37°C and with 5% CO2.
2.2.2. Actinomycin D treatment
For actinomycin D treatment experiment, S1 HMECs cultured on coverslips on
2D, were propagated initially in H14 medium supplemented with additives for 7 days
followed by an additional 3 days in H14 without EGF to induce growth arrest. Cells were
then treated with either vehicle Dimethyl Sulfoxide (DMSO) (Sigma-Aldrich) or 0.08
μg/ml of actinomycin D (Sigma-Aldrich) for 4 hours at 37 ° C and processed for
immunofluorescence staining as described in section 2.2.3.
2.2.3 Immunoflurescence labeling

Cells cultured on coverslips in 2D were washed in 1X phosphate buffer saline
(PBS) followed by the permeabilization treatment in 0.5% Triton X-100 (Sigma-Aldrich)
in cytoskeleton (CSK) buffer [100 mM NaCl (Mallinckrodt); 300 mM sucrose (SigmaAldrich); 10 mM Pipes (Sigma-Aldrich), pH 6.8; 5 mM MgCl2 (Sigma-Aldrich)]
containing protease inhibitor (CSK-PI). After washing twice for five minutes with CSKPI, cells were fixed for 20 minutes at room temperature with 4% formalin (SigmaAldrich). After rinsing thrice for 20 minutes at room temperature with PBS containing 50
mM glycine (PBS-glycine), cells were incubated for 1 hour at room temperature with
10% goat serum (Invitrogen Corporation) in immunofluorescence labeling (IF) buffer
[130 mM NaCl; 13.2 mM Na2HPO4; 3.5 mM NaH2PO4; 0.1% (w/v) bovine serum
albumin, RIA (Sigma-Aldrich); 0.05% (v/v) Tween 20 (Sigma-Aldrich)]. Cells were
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incubated overnight at 4°C with either mouse monoclonal antibody directed against
NuMA clone B1C11 (kind gift from Dr. Jeffrey Nickerson, University of Massachusetts),
CENPA, rabbit anti-serum against SMC3, RAD21 (kind gift from Dr. Jan-Michael
Peters, Research Institute of Molecular Pathology, Vienna, Austria) or rabbit polyclonal
antibody against NuMA (Abcam), Pol I (Santa Cruz), SMC1 (Bethyl Labs), Ki67 (Vector
Laboratories). Antibodies were diluted in IF buffer containing 10% goat serum to reach
the specified concentrations of ½ dilution, 26 μg/ml, 1/50 dilution and 1/50 dilution,
respectively. Following incubation with the primary antibody, cells were washed thrice
for 10 minutes with IF buffer, and incubated for 50 minutes at room temperature with
12.5 μg/ml fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit IgG
(Jackson Immunoresearch) and 6.7 μg/ml Alexa-Fluor 568-conjugated goat anti-mouse
IgG (InVitrogen Corporation) antibodies diluted in IF buffer containing 10% goat serum.
After three 10-minute washes with IF buffer, nuclei were counterstained for DNA with
0.5 μg/ml 4’, 6-diamidino-2-phenylindole dihydrochloride:hydrate (DAPI) (SigmaAldrich) in PBS for 10 minutes. After removal of excess DAPI, samples were mounted
with ProLong® Gold antifade reagent (Invitrogen Corporation).
2.2.4 Co-immunoprecipitation (Co-IP)
S1 HMECs cultured as monolayer (2D) for 12 days in 10 x 150 mm dishes
(VWR) were processed for co-IP following the protocol provided by the Universal
Magnetic co-IP Kit (Active Motif). The Co-IP products pulled down by the magnetic
beads were incubated in the protein loading buffer (10% Glycerol, 1.5% SDS) at 95°C
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for 5 minutes to elute proteins from the beads, and subjected to western blot analysis as
described in 2.2.5
2.2.5. Western blot analysis
Eluted Co-IP products in protein loading buffer or total protein extracts from cell
cultures prepared in Leammli buffer were loaded on SDS-PAGE gels. The percentage of
acrylamide was determined by the approximation of protein sample molecular weight.
5% gel was used to visualize proteins larger than 200 kD; 7.5% gel was used for proteins
between 40 and 200 kD; and 10% gel was used for proteins smaller than 40 kD. For
western blot analysis of proteins in Leammli extracts, 30 µg of sample was loaded per
lane and the target protein was detected with primary antibodies and secondary antibodies
at the concentrations recommended on the data sheet.
2.2.6 Chromatin immunoprecipitation followed by quantitative PCR (ChIP-PCR)
The protocol for ChIP was adapted from that of Dr. Steve Konieczny’s laboratory
and modified according to a published article (Lee, Johnstone et al. 2006). Specifically, 4
x 107 T4-2 cells cultured in 150 mm dishes were cross-linked with formaldehyde solution
(50 mM HEPES-KOH, pH7.5; 100 mM NaCl; 1 mM EDTA; 0.5 mM EGTA; 11%
formaldehyde) for 10 minutes and quenched with 0.125 M Glycine. After rinsing three
times with PBS, cells were harvested by scraping into a 15 ml falcon tube and kept at 80°C until use. Dynabeads Protein G (80 µl) (invitrogen #100.03D) were washed three
times in 1 ml blocking buffer (PBS with 0.5% bovine serum albumin (BSA) (Sigma; Cat.
No: A7906)) before being split equally and incubated with 2 µg NuMA antibody (Bethyl
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Lab, A301-510A) or IgG at 4°C for 6 hours. Antibody-beads (IgG-beads) were then
resuspended in 100 µl blocking buffer. Cells were thawed on ice and resuspended in 10
ml lysis buffer (10 mM Tris-HCl ,pH 7.5; 10 mM NaCl; 3 mM MgCl2; 0.5% IGEPAL; 1
mM PMSF ( freshly made) by gently pipetting and inverting for 5 minutes, then
centrifuged at 700 g for 5 minutes. The cell lysis step was repeated twice and cell pellets
were dissolved in 830 µl pre-IP dilution buffer (10 mM Tris-HCl, pH 7.5; 150 mM NaCl;
3 mM MgCl2; 1 mM CaCl2; 4% IGEPAL; 0.8% SDS, 1 mM PMSF (freshly prepared);
protease inhibitor cocktail, Roche (# 11873580001), freshly prepared). The tube was left
on ice for 5 minutes and the solution was diluted with 3x volumes of IP dilution buffer
(20 mM Tris-HCl, pH 8; 2 mM EDTA; 1% Triton X-100; 150 mM NaCl; Protease
Inhibitor cocktail, freshly prepared). Cells in solution were then subjected to sonication
with for 35 bursts, output 10 watt, with 20 seconds per burst and 90 seconds of pause
between two bursts in icy water. The sonicated solution was microcentrifuged at 14,000
rpm for 10 minutes to remove the cell debris, and 50 µl of sample was kept aside as input
control. The rest of the supernatant was split equally into two parts; each volume was
incubated with antibody-beads or IgG-beads by rotating at 4°C. After 2 hours of
incubation, the beads were collected and subjected to washes with 700 µl ChIP wash
buffer 1 (20 mM Tris-HCl, pH 8; 2 mM EDTA; 1% Triton X-100; 150 mM NaCl; 1 mM
PMSF, freshly prepared), buffer 2 (20 mM Tris-HCl, pH 8; 2 mM EDTA; 1% Triton X100; 0.1% SDS; 500 mM NaCl; 1 mM PMSF, freshly added), and buffer 3 (10 mM TrisHCl, pH 8; 1 mM EDTA; 0.25M LiCl; 0.5% IGEPAL; 0.5% Deoxycholate). Each
washing step was performed by gently inverting the tubes back and forth for 5 minutes at
room temperature. The beads were then transferred to a new tube for a final wash with
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700 µl of TE buffer. The collected beads were resuspended with 100 µl of elution buffer
and incubated at 65°C for 30 minutes. The elution buffer containing cross-linked protein
and chromatin products was transferred into a new tube. The beads were washed again
with same volume of elution buffer. Reversion of cross-linking was carried out by
placing the ChIP products and input sample at 65 °C over-night and all samples were
treated with RNase A (0.2 µg/ml) for two hours followed by two hours of treatment with
proteinase K (0.2 µg/ml). At last, the chromatin samples were purified with Qiagen PCR
Purification Kit and resolved in 50 µl EB.
The ChIP products were analyzed with real-time PCR on ABI 7300 with Sybr
green. The PCR program was set up as 55 °C for 2 minutes, 95 °C for 10 minutes, 95 °C
for 10 seconds, annealing at 58 °C for 1 minute, extension at 72 °C for 10 seconds, and
40 cycles.
2.3. Results
2.3.1. NuMA influences the nucleolar architecture
Overall, aforementioned evidence has suggested a potential relationship between
NuMA and nucleolar function. Nucleolar morphogenesis encompasses three parts,
namely active rDNA organization in the middle of nucleolus, the nucleolar-associated
proteins, and the perinucleolar heterochromatin. Because NuMA is observed associated
with the nucleolus and it is a structural protein, it might be important to maintain
nucleolar morphology. To assess nucleolar morphology, a DFC protein Fibrillarin was
immunolabeled in NuMA-silenced S1 cells (via small interfering RNA) and in control
cells transfected with siNon-Targeting (NT) RNA as shown in Figure 2.3.1.A. Moreover,
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a portion of centromere is preferentially associated with the nucleoli in the interphase cell
nucleus (Haaf and Schmid 1991) and because the centromere contains highly repetitive
DNA sequences, it becomes part of the perinucleolar heterochromatin. The possible
change of the perinucleolar heterochromatin organization has been assessed by immunolabeling the centromeres with an antibody against CENPA, a unique histone H3 variant
(Guetg, Lienemann et al. 2010), and we adopted a similar method to evaluate the
perinucleolar heterochromatin upon NuMA silencing. I found that while the typical
nucleolar protein, fibrillarin is distributed as discrete small dots in NuMA expressing
(siNT) control cells, it redistributes into large round foci associated with diffuse staining
in NuMA silenced (siNuMA) cells as shown in Figure 2.3.1.A. Because the nucleolar
regions are dark with DAPI staining of the nucleus, the approximate number of nucleoli
per cells can be determined by the number of these hollow regions combined with the
presence of Fibrillarin in these locations in DAPI/Fibrillarin stained cell nuclei. The
average number of nucleoli was significantly higher in control cells (2.2 ± 0.1) compared
to NuMA silenced cells (1.3 ± 0.1) as shown in figure 2.3.1.B. Overall, the average
number of CENPA associated with each nucleolus is significantly different in control
cells and in NuMA silenced cells, 5.7 compared to 7.8, which indicates alterations in
nucleolar morphology based on the number of nucleoli and the reorganization of
centromeric heterochromatin in the perinucleolar region upon NuMA silencing.
However, confocal microscopy will be needed to readily determine the exact location of
CENPA in relation to the nucleolus.
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Figure 2.3.1.

NuMA silencing influences nucleolar morphology. S1 cells were

transfected with siRNA against NuMA or scrambled small RNA as control followed by
the

immunostaining

for

NuMA/Fibrillarin/CENPA

in

siNuMA

cells

and

Fibrillarin/CENPA in siNonTarget transfected cells six days after the transfection (A),
size bar, 10 µm. More than 30 cell nuclei were randomly selected for each biological
replicate and analyzed for the number of nucleoli per cell nucleus with nucleoli (B) as
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well as the number of CENPA foci associated each nucleoli (C) in control and NuMA
silenced cells (**p<0.01, n=3).
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2.3.2. NuMA silencing affects nucleolar function with respect to rRNA transcription
The alteration of nucleolar morphology upon NuMA silencing gave rise to the
possibility that NuMA might influence nucleolar functions. The nucleolus is responsible
for rDNA transcription, rRNA processing, and ribosome assembly and transportation.
Our previous work has shown that NuMA is possibly involved in ribosomal biogenesis
(Jayaraman, Ph.D. Thesis, 2014). To re-assess NuMA’s influence on rDNA transcription,
FUrd assay of nascent rRNA level (Sarshad, Sadeghifar et al. 2013) was performed on S1
cells transfected with siRNA against NuMA. To eliminate the variation of FUrd signal
intensity due to different experimental treatments, we decided to compare signal intensity
in the nucleolar regions between cells with or without NuMA in siNuMA transfected
cells instead of between siNuMA and siNT transfected cells. Mean fluorescence intensity
in the nucleolar regions in NuMA expressing cells is about two folds higher than that in
NuMA silenced cells, which indicates that there is less nascent rRNA in NuMA silenced
cells as shown in Figure 2.3.2.A & B. Quantitative PCR assay of 45S pre-rRNA, 18S
rRNA, and 28S rRNA was also performed in NuMA silenced S1 cells and control siNT
cells. We observed the significant decrease of 28S, 18S, and NuMA RNA level in
siNuMA transfected cells, but the reduction of 45S pre-rRNA level was not statistically
significant as shown in Figure 2.3.2.C. The function of Pol I is essential for rRNA
production, we thereby assessed the distribution pattern as well as the expression level of
Pol I in NuMA silenced S1 cells by using immunostaining and western blot assay,
respectively. Interestingly, we observed that Pol I changed its distribution pattern, which
is more dispersed as indicated by arrows in Figure 2.3.2.D, in NuMA-silenced cells
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compared to more congregate staining in NuMA-expressing cells. Western blot analysis
of Pol I did not reveal an apparent change of expression in NuMA silenced cells as shown
in Figure 2.3.2.E. Given the fact that Pol I binds rDNA on the promoter and coding
regions, the dispersed distribution of Pol I likely reflects rDNA rearrangement upon
NuMA silencing. Therefore, it is reasonable to speculate that the decreased level of 28S
and 18S rRNAs is more likely the consequence of the disruption of rDNA organization
induced by NuMA silencing than the result of a change in Pol I expression level. It is
difficult to assess the localization of NuMA in the nucleolar region using
immunofluorescence. But upon the inhibition of rDNA transcription mediated by
actinomycin D, NuMA can be found in distinct perinucleolar regions or caps (Jayaraman,
S. Ph.D. Thesis, 2014). To assess the localization of NuMA and Pol I, S1 cells were
subjected to actinomycin D treatement and their locations were analyzed by
immunofluorescence. As shown in Figure 2.3.2.F, NuMA accumulates in the Pol I-free
region at the perinucleolus upon actinomycin D treatment, suggesting that NuMA and Pol
I do not interact when rDNA transcription is inhibited. Interestingly, both NuMA and Pol
I are both located at the nucleolar periphery, suggesting that they occupy different regions
of the perinucleolar chromatin under this particular condition.
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Figure 2.3.2.

NuMA silencing impairs rDNA transcription and disrupts Pol I

distribution in the nucleolus.

(A) FUrd incorporation assays in S1 cells subjected to NuMA gene knockdown by RNAi.
The nucleolar region in NuMA silenced cells are indicated by arrows. Transcription was
assessed by short FUrd treatment on cells for 20 minutes to allow its incorporation into
nascent nucleolar transcripts.

(B) Quantification of the FUrd foci after immunostaining and immunoflurescense
microscopy was performed by measurements on randomly selected nucleolar regions in
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the recorded images. The signal was quantified using ImageJ software. The average of
the mean grey values in NuMA expressing (NuMA+) cells was determined, and defined
as one hundred percent of signal. The average of the mean grey values measured in
NuMA silenced cells (NuMA-) was expressed proportionally. Each measurement was
performed on more than 30 cells and three replicates were carried out. Error bars
represent standard error. * P<0.05. Size bar, 10 µm

(C) Real-time PCR assay of 45S, 28S, 18S, and NuMA RNA levels was performed on
siNuMA and control siNT S1 cells as described before. The relative RNA level is shown
in the bar chart after being normalized to that of the internal reference gene PUM1.

(D) NuMA (green) and Pol I (red) dual-immunostaining was performed in S1 cells
transfected with siRNA against NuMA in 2D culture. Dispersed staining of Pol I in
NuMA silenced cells is indicated by the arrows. Cell nuclear edges are displayed by
using function “find edges” in Image J software. Size bar: 10 µm

(E) Western blot analysis of NuMA and Pol I was performed on cells transfected with
siNuMA and siNT. Lamin B was used as internal control. Signal intensity relative to
siNT is labeled under the bands.

(F) Dual-staining analysis of NuMA and Pol I location in the nucleolus after rDNA
transcription was inhibited with actinomycin D. Growth-arrested S1 cells on monolayer
culture were treated with actinomycin D at 0.08 µg/ml to specifically inhibit Pol I
transcription for 5 hours and subjected to dual-immunostaining for NuMA (green) and
Pol I (red). Size bar: 10 µm
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2.3.3. NuMA and the cohesin complex interact in interphase
NuMA has been long considered as a component of the nuclear matrix that
anchors the genome, but more evidence is still needed to support the original claim of
NuMA binding chromatin on the matrix attachment regions (MARs) through its S/TPXX
motifs (Luderus, den Blaauwen et al. 1994). Very interestingly, NuMA interaction with
the cohesin complex in S phase and M phase of the cell cycle has been reported
(Gregson, Schmiesing et al. 2001). Thus, it might be possible that NuMA regulates
chromatin organization through its binding with chromatin-associated complexes like
cohesin. To further explore this assumption, dual-immunostaining was performed for
NuMA and cohesin component SMC1 in non-neoplastic S1 cells induced to differentiate
into acini in 3D cell culture. Acini-like multicellular structures generated under 3D cell
culture mimic in vivo organization of mammary epithelial cells and importantly, the
distribution pattern of NuMA in vivo is accurately recaptured in acini produced in 3D
culture compared to monolayer cell culture on a plastic surface (Lelièvre, Weaver et al.
1998). Confocal imaging of the dual staining (Figure 2.3.3.A) showed that NuMA and
cohesin SMC1 are mainly overlapping at the periphery of the nucleolus as well as at the
periphery of the nucleus.
Based on the observation that NuMA and cohesin SMC1 co-localize at the
perinucleolus and the former result showing NuMA aggregation at the perinucleolus
upon treatment with nucleolar stress inducer, actinomycin D (Patricia A, M.S. Thesis,
2003), I tested whether cohesin could form “nucleolar caps” in response to actinomycin
D like NuMA does. Dual staining for NuMA and cohesin SMC3 was performed on
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growth-arrested S1 cells in 2D culture following treatment with actinomycin D at 0.08
µg/ml for five hours. Both NuMA and cohesin SMC3 were observed to aggregate at the
perinucleolus to form the “nucleolar cap” structure as shown in Figure 2.3.3.B. The
scoring results from three replicates (Table 2.3.1) revealed a significantly higher
percentage of cells simultaneously displaying both NuMA and SMC3 caps upon the
treatment compared to DMSO-treated control, although NuMA caps and SMC3 caps can
also be seen to occur independently from each other (i.e., the presence of NuMA caps in
one nucleolus does not mean that SMC3 caps are also present in that nucleolus and vice
versa).
High salt (2M NaCl) removes histones and soluble nuclear proteins to uncover the
underlying nuclear matrix. Several lines of evidence indicate that NuMA and cohesin
binding partner CTCF both bind to MARs (Luderus, den Blaauwen et al. 1994; Dunn,
Zhao et al. 2003; Yusufzai and Felsenfeld 2004). To assess if the insoluble fraction of
NuMA and cohesin can overlap, monolayer S1 cells were treated with 2M NaCl followed
by dual-staining for NuMA and cohesin SMC3. Figure 2.3.3.B shows that most of the
remaining NuMA overlaps with cohesin SMC3 at the edge of the DNA, which suggests
that NuMA and cohesin might interact at these locations. Interestingly, both DAPI and
SMC3 immunostaining results revealed a radial meshwork structure in the nucleus after
NaCl extraction; the NuMA foci located outside of the central dense DNA seem to be
present on these strings. Whether this meshwork structure represents the nuclear matrix
is unclear.
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To investigate whether NuMA could affect cohesin distribution, NuMA-GFP was
transiently over-expressed in breast cancer cells MCF7 following transfection with
lipofectmine2000. If NuMA indeed interacts with cohesin, I expected to see an influence
of NuMA over-expression on cohesin. Immunostaining for SMC3 was performed on the
NuMA-GFP transfected cells 24 hours post-transfection. Only GFP was transfected in
the control group.
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Figure 2.3.3. NuMA and cohesin overlap at the perinucleolus.
(A) Dual-immunostaining for NuMA (red) and cohesin SMC1 (green) in a differentiated
glandular structure (acinus) shows that NuMA and SMC1 partially overlap at the
perinucleolus as indicated by arrows. S1 cells in 3D culture were subjected to
immuostaining on day 12 followed by confocal imaging analysis.

(B) NuMA (red) and cohesin SMC3 (green) relocalize to the perinucleolus upon
actinomycin D treatment in non-differentiated (2D culture) growth-arrested cells. S1 cells
were cultured as 2D monolayer for 10 days and treated with actinomycin D (0.08 µg/ml)
for 5 hrs to halt rDNA transcription. The nucleolar caps are indicated by arrows. Size bar,
10 μm. A minimum of 300 nuclei were analyzed in each treatment and the percentage of
cells displaying NuMA nucleolar caps, SMC3 nucleolar caps, and NuMA/SMC3 double
nucleolar caps are shown in Table 2.3.3.1.
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(C) The distribution of NuMA and SMC3 after 2M NaCl extraction shows partial overlap
in the DNA region. Non-neoplastic S1 cells cultured on coverslips were extracted with
2M NaCl and 0.5% Triton for 15 minutes and subjected to immunostaining for NuMA
and SMC3 (middle panel) compared to cells without NaCl extraction (upper panel). Size
bar, 10 μm. NuMA (red) delineates dense chromatin (blue) in the center as well as at the
periphery of the nucleus; while SMC3 (green) entirely overlaps with the DNA in the
nucleus. The magnified colocalization of NuMA and SMC3 in one cell from the middle
right image (indicated by a white rectangle) is shown in the inset.

(D) Overexpressing NuMA induces aggregation of SMC3 at the perinucleolus in MCF7
cells. MCF7 cells were transfected with NuMA-GFP (lower panel) or GFP vector (upper
panel). Immunostaining for SMC3 (red) was performed 24 hours post-transfection.
Distinctive rings of SMC3 staining surrounding the nucleoli only occurred in NuMAGFP over-expressing cells as indicated by arrows in the lower left image but not in GFP
vector control cells. Size bar, 10 μm
Table 2.3.3.1.

Rep-1 ActD
DMSO
Rep-2 ActD
DMSO
Rep-3 ActD
DMSO

Percentage of cells displaying nucleolar caps from three replicates
NuMA caps (%)

SMC3 caps (%)

27
7.8
18
3.6
31
5.7

27
6
20
1
25
4.2

NuMA & SMC3
caps (%)
17.5
1.8
10
0.3
17.5
1.5
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2.3.4. NuMA and cohesin influence chromatin loops
The partial colocalization of NuMA and cohesin at the periphery of the nucleolus
and NuMA’s effect on cohesin distribution in the nucleolar region leads to the
assumption that NuMA might interact with cohesin. To test this hypothesis, coimmunoprecipitation for NuMA was carried out on growth-arrested S1 cells in 2D culture
to assess its interaction with cohesin. Our team previously identified ATPase SNF2h as a
binding partner of NuMA, and others also reported the interaction between cohesin and
SNF2h (Hakimi, Bochar et al. 2002). Figure 2.3.4.A shows that cohesin components
RAD21 and SMC3 were pulled down together with NuMA. SNF2h was co-precipitated
as well.

One major function of the cohesin complex is to mediate long distance interaction
in chromatin by generating chromatin loops. Silencing cohesin component like RAD21 or
SMC3 was reported to increase chromatin loop size that was detected by nuclear halo
assay (Guillou, Ibarra et al. 2010). The rationale behind the nuclear halo assay is that
after nuclear soluble proteins are removed by 2M NaCl, the underlying nuclear matrix
bound by the loosened chromatin is exposed. The unwrapped DNA loops extending out
of the permeabilized nuclear envelope can be visualized as a halo around the nuclear core
when a fluorescent DNA dye, like propidium iodide, is applied. To test NuMA’s potential
involvement in chromatin looping, nuclear halo assay was performed on non-neoplastic
S1 cells and neoplastic T4-2 cells silenced for NuMA. Both S1 and T4-2 cells showed an
increased ratio for the diameter of halo/nucleus in siNuMA cells compared to control
siNT, which supports the idea of NuMA’s involvement in chromatin looping. The effect
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of silencing SNF2h was analyzed in parallel in S1 cells because it interacts with both
NuMA and cohesin. No significant difference was observed between siNT-cells and
siSNF2h-cells indicating that SNF2h might not be involved in chromatin looping. Yet,
the silencing effect of SNF2h in S1 and T4-2 cells needs further validation by both
immunofluoresence staining and western blot.
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Figure 2.3.4. NuMA interacts with cohesin and influences chromatin looping.

(A) Interaction between NuMA, SNF2h and two components of cohesin (RAD21 and
SMC3). Nuclear extracts were prepared from growth-arrested non-neoplastic mammary
epithelial S1 cells and incubated with anti-NuMA antibody or non-specific
immunoglobulin (IgG) overnight for immunoprecipitation (IP).

Protein K coated

magnetic beads were used to attract anti-NuMA antibody or IgG. Shown are western blot
analyses of NuMA, RAD21, SMC3, and SNF2h on anti-NuMA antibody IP fraction
(NuMA IP) and IgG IP fraction.
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(B) Comparison of the ratio of halo/nucleus in NuMA silenced S1 and T4-2 cells. S1 (C)
and T4-2 cells (D) in 2D culture were treated with trypsin without EDTA on day 6 after
siRNA transfection and, following detachment from the culture vessels, they were
incubated in CSK buffer containing 2M NaCl, 0.5% Triton x-100, protease inhibitors,
and propidium iodide (10 µg/ml) for 3 minutes followed by imaging with a 40x
microscope lens. Control groups include siNT (NonTarget), and siSNF2h. The diameter
of the halo and the nuclear core were measured from more than 100 cells with Image J
under each treatment condition and the ratios of halo/nucleus were compared among
siNuMA and control groups (n=3). ** p value< 0.01; * p value<0.05.
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2.3.5.

NuMA and cohesin are preferentially enriched in specific regions of rDNA

Chromatin immunoprecipitation assay (ChIP) can be used to assess whether the
target protein can bind to a specific region of chromatin. Quantitative PCR assay is used
to validate the potential enrichment of the target protein on a specific chromatin region.
To test whether NuMA and cohesin co-occupy the same region of rDNA, ChIPquantitative PCR assay was performed to assess the potential enrichment of NuMA and
cohesin SMC3 on different regions of rDNA. Primers targeting rDNA promoter region
(pro-1), coding regions including 18S (H4), 5.8S (H8), 28S (H13), and nontranscribed
IGS regions (H18, H27, H32) were selected for the analysis; their positions are shown in
the drawing Figure 2.5.A. Because qPCR is a very sensitive technique, I observed large
variations regarding the number of cycles reaching the signal detection threshold when
different replicates with ChIP products were subjected to quantification, yet the
enrichment trends on the tested rDNA regions are fairly similar. To eliminate this type of
variations, two steps of normalization were carried out in my experiment in order to
obtain the final relative enrichment fold; i.e. the chromatin amount pulled down by the
target protein was first normalized to that of control IgG in each region and the obtained
relative fold enrichment at every region was further normalized to the assigned rDNA
region H4 to distinguish the potential significance of fold change among these rDNA
regions. The enrichment fold of DNA fragment in H4 is picked up as the reference
randomly for the second normalization. In fact, since it is the relative difference of
different regions that was analyzed in the study, any region could be used as the reference
and would not change the trend. The final ChIP-qPCR results showed that both NuMA
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(Fig.2.3.5.B) and cohesin SMC3 (Fig. 2.3.5.C) are preferentially enriched in the
nontranscribed IGS H27 region compared to coding regions H8 and H13 (p<0.05, Table
2.3.5.1 & 2.3.5.2). In fact, the enrichment of NuMA at H27 is more apparent since
statistical significance (p<0.05) was found in all comparisons between H27 and any other
regions (Table 2.3.5.1). The second highest enrichment region for NuMA is at H32 and
the T-test showed nearly significance (p=0.07) when compared to H8 and H13. SMC3
was also found to be more enriched at H32 based on the average enrichment folds, but it
was not statistically significant. Based on the above observations, an overall conclusion is
that NuMA and cohesin SMC3 are less enriched at H8 and H13 but co-enriched at H27.
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Figure 2.3.5. ChIP-qPCR assay of NuMA, cohesin SMC3, and Pol I on rDNA in T4-2
cells shows that NuMA and cohesin SMC3 are preferentially enriched in specific IGS
regions.

(A) Schematic diagram of human rDNA linear structure and the primers used in qPCR
assay targeting different regions. Purple bar: external transcribed spacers; yellow bar:
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internal transcribed spacers; rectangle: rRNA coding regions; blue line: intergenic spacer;
black bar: primers. The ChIP experiments followed by real-time PCR assay of NuMA
and SMC3 were performed on monolayer culture of breast cancerT4-2 cells to assess the
potential binding to different regions on the rDNA; IgG was used as nonspecific binding
control. The enrichment of NuMA and SMC3 at different rDNA regions relative to H4
was obtained from a two-step of calculation. First, the enrichment of NuMA and SMC3
at different rDNA regions relative to IgG was obtained by normalizing the input percent
of NuMA and SMC3 to that of IgG. Second, the relative enrichment at different regions
from the first step was further normalized to that of region H4. Pol I was used as positive
control to validate the ChIP assay on rDNA in two out of four replicate experiments.
Similar results of Pol I ChIP assay were obtained and one of them was shown in (D).
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Table 2.3.5.1. T-Test p-value of the relative enrichment of NuMA among tested regions
on rDNA (p-value has been round off to 2 decimals)

NuMA

pro-1

H4

H8

H13

H18

H27

H32

pro-1

-

0.04

0.04

0.02

0.90

0.01

0.25

H4

-

-

0.00

0.00

0.44

0.01

0.49

H8

-

-

-

0.92

0.36

0.00

0.07

H13

-

-

-

-

0.37

0.00

0.07

H18

-

-

-

-

-

0.01

0.32

H27

-

-

-

-

-

-

0.01

H32

-

-

-

-

-

-

-

Table 2.3.5.2 T-Test p-value (round off to 2 decimals) of the relative enrichment of
SMC3 among tested regions on rDNA

SMC3

pro-1

H4

H8

H13

H18

H27

H32

pro-1

-

0.03

0.25

0.82

0.74

0.01

0.27

H4

-

-

0.00

0.00

0.37

0.06

0.71

H8

-

-

-

0.18

0.34

0.00

0.14

H13

-

-

-

-

0.64

0.01

0.23

H18

-

-

-

-

-

0.07

0.42

H27

-

-

-

-

-

-

0.51

H32

-

-

-

-

-

-

-

Tables 2.3.5.1 & 2.3.5.2 show the p values of T-tests between the two groups of
enrichment folds from the comparison of any pair of rDNA regions.
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2.3.6.

NuMA affects Ki67 distribution

After unveiling that NuMA impacts both nucleolar morphology and function, I
have explored whether NuMA can influence cell cycle marker Ki67. Ki67 is expressed in
all phases of active cells but absent from quiescent cells, which makes it an important
marker to indicate cell growth in cancer diagnosis in clinical (Scholzen and Gerdes
2000). Recent studies also showed that Ki67 is involved in rRNA transcription regulation
(Bullwinkel, Baron-Luhr et al. 2006; Rahmanzadeh, Huttmann et al. 2007). In addition to
the well-known fact of NuMA stabilizing the spindle poles during mitosis, which is
essential for the completion of cell division (Silk, Holland et al. 2009), mounting
evidence also supports the role of nuclear NuMA in cell cycle progression during the
interphase (Chandramouly, Abad et al. 2007; Endo, Moyori et al. 2013; Vidi, Liu et al.
2014). Therefore immunostaining for cell cycle marker Ki67 in NuMA over-expressing
MCF7 cells was carried out. NuMA cDNA or GFP-NuMA was transiently expressed in
MCF7 cells and empty vector or GFP only was transfected in parallel to be used as
control. Ki67 staining displays distinct distribution patterns at different stage of the cell
cycle (van Dierendonck, Keijzer et al. 1989), based on which, six patterns (and their
roughly corresponding stages) were characterized in this study including no staining
(quiescence), speckles (early G1), speckles & foci (G1), two or more foci (late G1, S, and
G2), homogenous staining (M), and single spot as shown in the lower panel in Figure
2.3.6.A. Ki67 staining as a single spot within the enlarged nucleolus has been commonly
observed in NuMA silenced S1 cells (data not shown) and it is most likely to represent a
specific stage of a cell with reduced nucleolar activities before exiting the cell cycle to
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enter G0.

The percentages of cells in each category based on Ki67 patterns were

compared between the treatment groups and control groups as shown in the bar chart in
Figure 2.3.6.A. The percentage of control cells with speckles and speckles & foci is
significantly higher in control cells than in the treated cells; in contrast, a higher
percentage of cells with over-expression of NuMA display a single spot of Ki67 staining.
These observations suggest that NuMA affects Ki67 distribution, when NuMA is overexpressed. Although levels of cyclins would have to be measured to correlate changes in
Ki67 distribution with an alteration of the cell cycle, the increased presence of cells with
a single spot of Ki67 staining might be related to a change in the number of nucleoli that
has been correlated with cell proliferation activity (i.e., the more nucleoli the higher the
proliferation activity). But as explained above, the exact stage of the cell cycle in which
these cells are requires further investigation. We also observed an increased percentage of
cells without Ki67 staining in NuMA over-expressing cells, which indicates there is an
increased number of quiescent cells upon over-expression of NuMA. These changes are
accompanied with a dramatic decrease in the percentage of cells with multiple speckles
and small foci of Ki67 staining as well as cells with diffused homogenous staining.
Overall, our observations suggest that an excessive amount of NuMA hinders impairs
proliferation based on the absence of Ki67 staining on a per cell basis.
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Figure 2.3.6. NuMA influences Ki67 distribution and expression in MCF7 cells

The percentage of cells with different Ki67 patterns upon NuMA over-expression (upper
panel) and the characterized Ki67 distribution staining (lower panel) in MCF7 cancer
cells. MCF7 cells cultured in 2D were either transfected with GFP-NuMA or with
pCMV-NuMA to trigger over-expression of NuMA. Empty vector pCMV and GFP
transfected cells were used as controls. Immunostaining for Ki67 was carried out 24
hours after the transfection. Under each treatment, more than 300 cells were scored and
the percentages were compared based on the six different distributions of Ki67 as shown
in the lower panel. The error bar represents standard error (n=3).
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2.4. Discussion

NuMA is a multifunctional protein localized in the cell nucleus beside its
presence at the mitotic spindle poles. To this date the possible proposed roles for NuMA
in the cell nucleus are an involvement in the building of a nuclear matrix (Berezney and
Coffey 1974), apoptosis (Hsu and Yeh 1996), gene transcription control (Harborth,
Weber et al. 2000), chromatin organization (Abad, Lewis et al. 2007), and DNA repair
(Vidi, Chandramouly et al. 2012). Cell cycle reentry upon alteration of NuMA
distribution in reverted malignant mammary epithelial cells, associated with chromatin
reorganization, was also reported (Chandramouly, Abad et al. 2007), suggesting a link
between NuMA function in chromatin regulation and biological consequences in cell
quiescence control. In an effort to elucidate the underlying mechanism of how NuMA
controls chromatin organization and thus, possibly exerts its influence on the cell cycle, I
conducted the study presented above on the role of NuMA in the regulation of nucleolar
architecture and function.

The nucleolar architecture was assessed upon NuMA silencing based on three
aspects, such as the number of nucleoli, the distribution of nucleolar proteins Fibrillarin
and Pol I, and the number of the centromeres as indicated by CENPA staining associated
with the nucleolus. My results showed that while the number of nucleoli is decreased in
NuMA silenced cells, the average number of centromeres associated with each nucleolus
is increased. The number of nucleoli is positively correlated with the requirement for
ribosome biogenesis in these cells, which can be exemplified by the extreme case of
cancer cells (Derenzini, Montanaro et al. 2009). Therefore, the decrease of the number of
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nucleoli in NuMA silenced S1 cells likely reflected the lesser requirement for ribosomes
in these cells probably due to the global reduction in cellular activities. In support of this
hypothesis, an overall reduction of rRNAs in NuMA silenced cells was confirmed by
qPCR assay of individual rRNA species and the FUrd assay of nascent rRNA.
Interestingly, an overall reduction of nascent mRNA was also observed in the FUrd assay
(results not shown), suggesting that the influence of NuMA silencing on RNA production
is global in the nucleus rather than limited to the nucleolus. The increased average
number of CENPA associated with nucleoli in NuMA silenced cells signifies that more
centromeres are associated per nucleolus when NuMA is absent, suggesting an impact on
heterochromatin organization at the nucleolar periphery. A subset of centromeres are
routinely observed to associate or reposition to the nucleoli in the interphase of the cell
cycle from Drosophila (Padeken, Mendiburo et al. 2013) to human cells (Wiblin, Cui et
al. 2005), but the biological function of such phenomenon is not clear so far. Linear
proximity between NORs and the centromeres on human acrocentric chromosomes
enables these centromeres to associate with the nucleoli, yet it has not been addressed
whether centromeres on other chromosomes are equally likely to anchor on the surface of
nucleoli. The newly recruited centromeres can be from two sources: either from those
acrocentric centromeres that used to be part of other nucleoli, or from any chromosomes
recruited by chance. Based on studies from others (Krystosek 1998; Sullivan, Bridger et
al. 2001), I favor the first explanation. It would suggest a dynamic microenvironment
favoring chromosome repositioning in the nucleus in the absence of NuMA. Nonetheless,
this observation may provide a new angle to study how NuMA controls higher-order
chromatin organization.
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Pol I staining in NuMA silenced cells revealed a less constrained distribution
pattern of Pol I foci in the enlarged nucleolar region. Without labeling rDNA, I was not
able to conclude whether the reorganization of rDNA occurs upon NuMA silencing. Yet,
the unchanged Pol I level assessed by western blotting and the less constrained Pol I foci
in NuMA silenced cells leads me to assume that the decrease in rRNA levels that I also
measured is more likely caused by the rearrangement of rDNA, although we cannot rule
out an impact on complexes involved in transcription and interacting with NuMA like BWICH (Jayaraman S, Ph.D. 2014). Overall, changes in the nucleolus from these three
angles bring enough evidence to conclude that NuMA influences nucleolar architecture.

Both FUrd assay and RT-qPCR were performed to test if the levels of rRNAs are
affected in NuMA silenced cells. Results on nascent RNAs with FUrd revealed that
rRNA transcription is indeed impaired by NuMA silencing. RT-quantitative PCR results
showed that only 28S and 18S but not 45S rRNA levels are significantly decreased in
NuMA silenced cells. The 28S rRNA and the 18S rRNA are produced from the 45S prerRNA after the cleavage of internal transcribed spacer sequences and external transcribed
spacer sequences (Boisvert, van Koningsbruggen et al. 2007). Thus, our results also tend
to indicate that the rRNA processing steps are impaired by NuMA silenced cells.
However, it should be noted that 45S pre-rRNA was largely decreased in two out of three
biological replicates; thus the lack of statistical significance for the average decrease of
45S rRNA level is influenced by the one replicate that displayed no change. The possible
reason for the variation among biological replicates is likely the extremely short life-span
of 45S pre-rRNA, which can only exist for several minutes (Popov, Smirnov et al. 2013)
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before being processed. Further investigation of 45S pre-rRNA level is needed to bring a
definitive conclusion.

To understand the mechanism by which NuMA controls nucleolar architecture,
especially rDNA organization, a literature search was conducted in order to find out if
NuMA has any binding partner functioning in chromatin remodeling. The identified
interaction between NuMA and the cohesin complex in S phase and M phase of the cell
cycle (Gregson, Schmiesing et al. 2001) has attracted my interest because cohesin is a
well-known global player in chromatin organization (Merkenschlager 2010). More
importantly, a causal relationship between a dysfunctional cohesin and reduction in the
number of ribosomes has been repeatedly observed in a group of diseases termed
cohesinopathies (Bose and Gerton 2010). Cohesinopathies are the genetic diseases
specifically caused by mutated proteins involved in the cohesin network. Since the
cohesion of sister chromatids is not significantly affected in these diseases, it is usually
thought that the mutations impair the function of cohesin in chromatin organization and
transcription control. In light of the published results showing the interaction between
NuMA and cohesin in S and M phases, I also assessed this interaction in the cell nucleus
of nonproliferating cells. The overlap of NuMA and cohesin notably occurred at the
periphery of the nucleolus and the periphery of nucleus in cells in 3D culture, and in the
insoluble nuclear features where the proteins remained closed to the DNA after soluble
proteins were removed by high salt. Thus, NuMA and cohesin preferentially overlap at
heterochromatin-enriched

regions

in

non-neoplastic

differentiated

cells.

The

colocalization of NuMA and cohesin was also assessed in quiescent non-neoplastic S1
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cells cultured in 2D (no acinar differentiation), but because both proteins displayed strong
fluorescence signal in the nucleus, it was difficult to identify the colocalization pattern
(Data not shown). At least a portion of both NuMA and cohesin remains following high
salt extraction, possibly as constituents of the nuclear matrix. The merged images of
remaining NuMA, cohesin SMC3, and DNA in the nuclei after salt extraction show that
cohesin staining is almost completely overlapping with DNA while NuMA is distributed
into dispersed foci overlapping with DNA, which suggests NuMA and cohesin might
only partially share chromatin functions. This is consistent with the observation from
cells in 3D culture that the overlap of NuMA and cohesin occurs in particular locations in
the cell nucleus. Hence, we could assume that although these proteins might work in
concert under certain circumstances, they also act independently. This hypothesis is
supported by results with the formation of nucleolar caps upon halting rDNA
transcription with actinomycin D, showing that the two proteins are not always
simultaneously involved depending on the cells.

It is known that NuMA and cohesin both bind Rae-1 at the mitotic spindle pole to
coordinate the assembly of the mitotic spindle (Wong and Blobel 2008; Kong, Ball et al.
2009) during metaphase, but the functional interpretation for NuMA and cohesin
interaction in S phase remains elusive (Gregson, Schmiesing et al. 2001). To rule out
other potential chromatin activities mediated by NuMA and cohesin, like DNA
replication, and merely focus on the transcription control and subsequently quiescence
maintenance, co-IP for NuMA and cohesin was performed exclusively in the nucleus of
growth-arrested cells. Co-IP assay results showed that cohesin SMC1 and RAD21 were
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pulled down by NuMA together with SNF2h. As mentioned above, SNF2h is an ATPase
associated with NuMA (Vidi, Liu et al. 2014), but it is also needed for loading cohesin on
the chromosomes by the nucleosome remodeling and deacetylase (NuRD) complex
(Hakimi, Bochar et al. 2002).

NuRD contains HADC1/HADC2 enzymes that are

important to initiate heterochromatinization (Allen, Wade et al. 2013). Thus, it seems
logical to observe cohesin appearing in the perinucleolar heterochromatin region given
that it works together with NuRD. Unfortunately, the reciprocal IP for cohesin
components failed to bring down NuMA (data not shown). A technical explanation
would be that the antibody used to IP cohesin disrupted the interaction. Based on the
study of NuMA and cohesin in metaphase, their interaction seemed to be mediated by
Rae-1 but it was never addressed whether NuMA and cohesin interact directly (Wong
and Blobel 2008). If their interaction were indirect, distinct affinities of NuMA and
cohesin for a third protein might complicate the coimmunoprecipitation results.
Nevertherless, based on current knowledge, several scenarios could be proposed for the
interaction between NuMA and cohesin. It is possible that NuMA and cohesin interact
through their binding to the same region of chromatin. Published work indicates that
NuMA and cohesin bind MARs(Luderus, den Blaauwen et al. 1994).

A DNAse

treatment prior to co-IP would degrade DNA not embedded in the nuclear matrix and
disrupt the association between NuMA and cohesin at these locations, hence the proteins
would not co-PI anymore; however, their potential interactions as part of nuclear matrix
through MARs could still remain and the two proteins would still co-IP, but possibly to a
lesser extent. Another scenario is that NuMA and cohesin interact directly or via a third
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protein independently of DNA binding. In this case, the treatment with DNAse would not
influence the IP result.
The timing of NuMA and cohesin in their interaction with chromatin also points
out to complementary yet independent functions. The binding between cohesin and
chromatin at different phases of the cell cycle is relatively well characterized compared to
that of NuMA. Cohesin is loaded on chromatin in telophase in metazoans. The binding of
cohesin to chromatin in G1 phase is believed to be dynamic rather than “stable” due to
the observation that it takes shorter time for the nearly whole population of cohesin to
dissociate from chromatin upon photobleaching compared to the time necessary in other
phases of the cell cycle (Gerlich, Koch et al. 2006). NuMA enters cell nucleus in
telophase as well and at least a fraction of NuMA associates with chromatin. The
interaction between NuMA and cohesin in G0/G1 phase was observed in my present
study. Work from others also indicates a possibility of NuMA and cohesin co-occupying
the same chromosomal regulatory elements to regulate gene transcription (please see
Chapter 4 final discussion) (Tarallo, Bamundo et al. 2011) (Tarallo, Bamundo et al.
2011).
Distinct recovery times within the cohesin population upon photobleaching after
G1 phase has raised the hypothesis that cohesin is likely present in different pools
committed to different functions in S and G2 phases. It is now generally accepted that the
dynamic cohesin-chromosome binding is mainly responsible for gene transcription
regulation by mediating intrachromosomal interactions. Stable cohesin-chromosome
binding is proposed for chromatids cohesion via interchromosomal interactions (Gerlich,
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Koch et al. 2006; Jeppsson, Kanno et al. 2014). NuMA and cohesin interaction in S
phase has been reported to occur in a small population of both proteins (Gregson,
Schmiesing et al. 2001); however, it has not been addressed under which circumstance
the interaction takes place. Given the fact that both NuMA and cohesin are also involved
in DNA repair, it would not be surprising to see their interaction occur in a specific pool
either for transcription regulation or for DNA repair.

The release of cohesin from

chromosomes and NuMA from the nucleus occurs in prophase. NuMA is likely relocated
to the spindle pole area by the end of prophase, while most cohesin detaches from
chromosomal arms by the end of metaphase except for centromeric cohesin that is
removed at the beginning of anaphase and thus, allows the segregation of sister
chromatids (Horsfield, Print et al. 2012).

These findings tend to indicate that the

interaction between NuMA and cohesin is likely involved in the pool of cohesin that
detaches from the chromosomes early on instead of those after the prophase. In addition,
a small amount of cohesin accumulates at the spindle poles, hence interacting with
NuMA during mitosis; but the biochemical specificities of these cohesin complexes have
not been characterized yet, so we cannot rule out the possibility that this fraction of
cohesin also represents a different pool in the interphase nucleus.

To my best knowledge, we are the first laboratory to show that both NuMA and
cohesin form “nucleolar cap” structures upon Pol I inhibition induced by actinomycin D.
The formation of nucleolar caps usually coincides with nucleolar stress, like that induced
by the blockage of the ribosome biogenesis network, the inhibition of mRNA
transcription and the induction DNA damage (Shav-Tal, Blechman et al. 2005). The
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biological functions of these cap structures are not known currently. Interestingly,
different proteins were observed to form nucleolar caps depending on distinct stresses,
hence indicating a specificity of the stress reaction (Malekkou, Lederer et al. 2010). In
this sense, NuMA and cohesin are functionally-related in the stress reaction upon rRNA
transcription blockage. Among cells forming caps, over 50% show the simultaneous
presence of NuMA and cohesin caps around the nucleoli while other cells only contain
nucleolar caps formed by either NuMA or cohesin, indicating that NuMA and cohesin
might behave independently from each other. This idea is supported by the fact that the
cohesin cap can still form in NuMA silenced cells upon actinomycin D treatment (data
not shown). Another interesting observation is that NuMA aggregates at the periphery of
the nucleolus without any overlap with caps formed by Pol I (Figure 2.3.2.F) after the
treatment with actinomycin D. Under such condition, the formerly active rDNA arrays in
the interior of the nucleolus compact and reposition to the nucleolar edge, where they are
flanked by the perinuclolar heterochromatin including silent rDNAs, neighboring
proximal and distal chromosome regions and other heterochromatin (Guetg, Lienemann
et al. 2010; Floutsakou, Agrawal et al. 2013). Thus, it may be concluded that NuMA
might exclusively overlap with the perinucleolar heterochromatin after Pol I is inhibited.
It should be also pointed out that the reaction of NuMA upon nucleolar stress seems to be
cell-type or cell-cycle dependent. NuMA was not reported to form the nucleolar cap
structure in some cancer lines used in the study (Shav-Tal, Blechman et al. 2005). Upon
comparison between non-neoplastic S1 cells and malignant T4-2 cells, I observed that
NuMA caps in T4-2 cells are less obvious than those in S1 cells. This reaction of NuMA
seems to be related to cell quiescence status considering that NuMA-formed nucleolar
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cap can be clearly observed only in non-neoplastic cells that exited the cell cycle (Abad,
P. M.S. Thesis, 2003).

Cohesin functions in chromatin looping, which is illustrated with the nuclear halo
assay. Cells with silenced RAD21 or SMC3 produce larger halo size compared to the
control cells (Guillou, Ibarra et al. 2010). This may be explained by the loss of integrity
of the nuclear matrix structure, so that it cannot provide enough chromatin anchoring
points, which leads to the longer chromatin loops reflected by the halo size. Results from
halo assays performed on NuMA-silenced S1 cells and T4-2 cells showed a significant
increase in halo size compared to control cells. It is likely that the effect is
underestimated because of the low transfection efficiency of the HMT-3522 cell series.
The mechanism by which cohesin mutations induce defects in ribosome
biogenesis in Cohesinopathies is not clear. Although a claim has been made in a review
article that cohesin regulates rDNA loops by binding IGS (Xu, Lu et al. 2014), the related
evidence is not seen yet by the time this thesis is written. A recent study of the budding
yeast strain with ECO1 mutation, a homolog of human cohesin acetyltransferase ESCO2
that causes one type of cohesinopathies if mutated, showed that slowed-down sliding of
cohesin along the rDNA replication forks decreases rDNA transcription efficiency (Lu,
Lee et al. 2014). However, many mysteries still remain. For example, what is the
relationship between the cohesin binding sites for rDNA transcription and replication?
Moreover, the slowed-down rDNA replication as well as on other genomic regions
should directly lead to prolonged S phase, yet this was not reported in the cells from
patients so far. ChIP-qPCR was performed in my study to assess the potential binding

87
regions of NuMA and cohesin on rDNA. A preferential binding at IGS compared to
coding regions was revealed for both NuMA and cohesin SMC3 on rDNAs in T4-2 cells
and the same pattern was recaptured in MCF7 cells (data not shown). In the statistical
analysis, a random region (H4) on rDNA was selected as the reference for the secondary
normalization of the relative fold enrichment at different tested rDNA regions. I found
that this was a necessary step in the analysis because a similar enrichment trend was seen
among the biological replicates of ChIP experiments but the enrichment folds varied
largely from one replicate to another. A chromosome region closed to MYC gene was
selected as the negative binding control for cohesin based on the literature at first, but I
soon found out that it is not practical due to the difference in the gene copy number. The
normal genome contains only two copies of most genes but there are about 400 copies of
rDNA. High background was produced even for the IgG binding at rDNA compared to
other regions. To eliminate the variations of antibody (and IgG) binding efficacy at
different regions and to eliminate the variations of enrichment folds due to technical
issues among the biological replicates, two rounds of normalization were carried out at
each individual region in the final statistical analysis.
Human rDNA IGS harbors regulatory elements responsible for rDNA
transcription at its 5’ and 3’ ends adjacent to the transcribed region (seen Figure 1.7.1),
but for most parts of the DNA segment between the two terminal regions of IGS potential
functions remain largely unknown. In present study, NuMA was found to preferentially
bind to region H27 of the IGS, 27kb downstream of the transcription start site. Published
sequence analysis revealed that pyrimidine (thymine and cytosine) is almost exclusively
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present in the region spanning from 25kb to 27kb (Gonzalez and Sylvester 1995), which
might provide a clue of the DNA pattern for NuMA binding. In addition, three tandemly
arranged A-containing motif “ActcA blocks” are located at 26,866 – 27,125 bp in this
pyrimidine-enriched region. A repeat element named “butterfly”, due to the pattern
shown on the sequencing gel, was also assigned at 27,271 – 27,859 bp. Yet, functional
studies related to these motifs are not available, although it was speculated that the IGS
fragment containing these putative motifs might contribute to anchoring rDNA at the
edge of the nucleolus (Kaplan, Murray et al. 1993; Gonzalez and Sylvester 1995).
My results have shown that NuMA silencing results in rRNA transcription
inhibition and NuMA preferentially binds IGS H27. It is reasonable to assume that
NuMA silencing will decrease its presence at rDNA IGS regions. This effect would be
concomitant with the reduction in rDNA transcription, hence potentially linking NuMA
binding to H27 and rDNA transcription. However, the question remains of whether
NuMA is present solely in active rDNA or at both inactive and active rDNA. The ChIP
assay for Pol I and histone markers specific of active or inactive rDNA in NuMA
silenced cells, as well as ChIP (NuMA)-reCHIP (markers of interest) assays in cells
expressing NuMA, might help answer this question. Although my current ChIP data
supports the preferential binding of NuMA and cohesin to IGS, it does not prove that
these proteins are involved in the loop structure in the rDNA. To further test the potential
loop organization, 3C assay is required.
At the end of my project, an initial preliminary effort was made to assess the role
of NuMA in cell cycle progression. Given that the impairment of rDNA transcription
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was observed in NuMA silenced S1 cells, cell cycle arrest should be expected in NuMAsilenced cells. However, it is not that simple. Indeed, others have observed that NuMA
silencing does not necessarily lead to cell cycle arrest (Endo, Moyori et al. 2013; Vidi,
Liu et al. 2014). This situation is partially caused by the fact that NuMA is a stable
protein and it is not easy to completely deplete it from the cells (Silk, Holland et al.
2009), especially in the rapidly growing cancer cells. Flow cytometry quantification of
DNA following NuMA silencing with siRNA indicated possibly a cell-type dependent
effect on the cell cycle (Vidi, Liu et al. 2014). For example, the percentage of cells in
G0/G1 phase was slightly increased in mammary epithelial cell lines, MCF7 and S1. But
it decreased slightly in human osteosarcoma U2Os and remained unchanged in leukemia
K562 cells. Therefore, in an effort to better understand the relationship between NuMA
and proliferation control, cancer cells over-expressing NuMA were analyzed in my
experiments. Based on the staining pattern of Ki67, which is also a nucleolar protein
during the interphase of the cell cycle, I observed that an increased population of cells
accumulates in prolonged G1 and probably also in G0 phase, as shown by the lack of
Ki67 expression in these cells. The rRNA level and ribosome level have not been
assessed yet in these cells. Future experiments should investigate the expression pattern
of different cyclins by dual immunostaining with Ki67 to better correlate the observed
changes in Ki67 distribution and an alteration of the cell cycle. Cyclin E reaches its peak
as cells enter S phase. Cyclin A and cyclin B elevate to the highest level in G2 and M
phase, respectively. Nevertheless, overall results suggest that too much or too little
NuMA both impact proliferation. It is possible that, as for NuMA silencing, NuMA over-
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expression also disrupts nucleolar structure and function via an imbalance of binding at
IGS.
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CHAPTER 3: CDS1 IS FUNCTIONALLY INVOLVED IN CELL POLARITY
CONTROL AND CANCER INVASION

3.1 Introduction
Basoapical polarity is a hallmark of functionally differentiated epithelia. The
formation of apical polarity acting as a tumor suppressor has been reported previously,
and deregulation of some tight junction proteins contributes to cancer invasiveness as
well as metastasis (Qiu, Abo et al. 2000; Huang and Muthuswamy 2010). Our laboratory
previously demonstrated that the integrity of apical polarity is critical for breast epithelial
cells to remain quiescent and proposed that the existence of apical polarity is a “brake” to
prevent quiescent cells from reentering the cell cycle (Chandramouly, Abad et al. 2007).
To identifiy the gene-expression profile related to apical polarity regulation, whole
genome analysis at the mRNA level was performed in glandular structures (acini)
produced in 3D culture with and without apical polarity. CDS1 was one of 30 genes
identified to be significantly down-regulated upon apical polarity disruption (Cardenas
JM, Ph.D. Thesis, 2012).
CDS1 is critical for phosphatidic acid metabolism and encodes an enzyme that
catalyzes the production of CDP-diacylglycerol (CDP-DAG) using cytidine triphosphate
(CTP) and PA as substrates. CDP-DAGs react with inositol to generate PIs, which are the

103
precursors of phosphatidylinositides including phosphatidylinositol phosphate (PIP),
phosphatidylinositol biphosphate (PIP2), and phosphatidylinositol triphosphate (PIP3).
These phophatidylinositides are important molecules involved in multiple signaling
pathways conducting various functions (Vivanco and Sawyers 2002; Bharill, Ayyadevara
et al. 2013). In mammals, the oncogenic protein AKT is activated after it directly binds to
cell membrane-located PIP3, resulting from the conversion of PI(4,5)P2 by Pi3K (Auger,
Serunian et al. 1989). The transition balance between PIP2 and PIP3 is controlled by the
antagonistic functions of Pi3K and PTEN, both of which are among the most frequently
mutated genes in cancer (Watson, Takahashi et al. 2013). Indeed, constitutively elevated
PIP3 is reported in most cancer cells (Vanhaesebroeck, Leevers et al. 2001) , suggesting a
critical involvement of the phosphatidylinositide biosynthesis pathway in cancer
development and progression. Loss-functional mutated cds, the human CDS1
homologous gene in Drosophila, leads to the decrease of PIP2 level in photoreceptor cells
in eyes, but this effect is thought to be specifically caused by the eye-cds isoform since it
was not observed in other cell types (Wu, Niemeyer et al. 1995). The global impact of
CDS to the organism is just getting recognized through a recent study in Drosophila. By
silencing the CDS gene with RNAi, the Huang group reported an increase of lipid storage
indicated by the level of triacylglycerol (TAG) and a decrease of PIs in Drosophila
salivary gland cells as well as in the larva (Liu, Wang et al. 2014). The production of PIs
and TAG in Drosophila is carried out by two different pathways using PAs as common
precursors and branched thereafter. Loss of CDS function resulted in the blockade of PIs
synthesis pathway, hence reinforcing the previous observation in eye photoreceptor cells
(Wu, Niemeyer et al. 1995), and therefore diverted most precursor PAs to produce TAG.
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Very interestingly, size reduction was observed in the salivary gland cells with silenced
CDS while the number of cells was not changed, suggesting that the influence of the
decrease in PI level is mainly on cell growth rather than on cell proliferation. Yet, neither
cell size nor TAG accumulation was affected by CDS silencing in fat body cells (Liu,
Wang et al. 2014), indicating that the lipid metabolism pathways regulating cell growth
are cell-type dependent.
In contrast to Drosophila, that contains only one CDP-DAG synthase gene, the
human genome contains two CDS genes, CDS1 and CDS2 sharing 69% identity at the
amino acid level (Halford, Dulai et al. 1998). In addition, Tam41 has also been reported
recently to perform the same function as CDS in yeast mitochondria (Tamura, Harada et
al. 2013), but the role of its homolog in human, Tamm41, is not clear. The investigation
of the expression profile of CDS1 and CDS2 in mouse embryo and adult tissues shows
that CDS1 only specifically expresses in brain, eye, and smooth muscle in contrast to
CDS2, which is more universally expressed in multiple tissues (Volta, Bulfone et al.
1999; Inglis-Broadgate, Ocaka et al. 2005). The subcellular localization of CDS1 and
CDS2 is similar; both proteins are exclusively expressed in the cytoplasm and
concentrated in the endoplasmic reticulum (ER) (Inglis-Broadgate, Ocaka et al. 2005).
Recent evidence also suggested that CDS1 and CDS2 might use different PA pools as
substrates distinguished by the acyl chain of the lipid (D'Souza, Kim et al. 2014).
Studies performed in vertebrate cells have provided more complicated results
regarding the function of CDS. Monkey kidney COS-7 cells transfected with CDS1
cDNA failed to elevate PI levels although the enzyme activity was 7-fold increased

105
(Lykidis, Jackson et al. 1997). Zebrafish mutant with CDS2 loss-of-function displayed
decreased PIP2 levels that, consequently, caused the failure of vascular morphogenesis
(Pan, Pham et al. 2012). The defect in angiogenesis in cds2 mutants was recaptured by in
vitro invasion assays in cell culture of human endothelial cells HUVEC with CDS1 or
CDS2 silenced by RNAi. Moreover, silencing CDS2 slightly reduced the number of
endothelial cells in the zebrafish embryo, yet it was not reported whether cell
proliferation was impaired as well in vitro.
Collectively, current evidence suggests that loss of CDS function causes PIP2
reduction, which is likely to hinder cell growth, cell proliferation and even cell invasion
depending on the cell type. Therefore, in light of the influence of CDS on major aspects
associated with cancer and our recent discovery that CDS1 might be linked to basoapical
polarity, an essential feature of breast homeostasis also involved in proliferation and
invasion control, it is necessary to further characterize CDS1’s influence in the mammary
epithelium in order to better unravel its potential role in breast cancer initiation and
progression.
3.2.

Materials and methods

3.2.1 Cell culture
3D drip method for cell culture was described as in Chapter 2.2.1.
3D embedded method was applied in all the experiments containing invasive
ductal carcinoma MDA-MB-231 cells. Briefly, a thin layer of MatrigelTM was coated on
the container surface at 10 µl/cm2 and the gel was allowed to solidify for 5 minutes at
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37ºC. Cells were suspended in MatrigelTM containing 10% H14 medium at the density
830,000/ml for S1 cells (below passage 60) and 415,000/ml for S1 cells at passage 180
(S1p180), S2 cells, T4-2 cells, and MDA-MB-231 cells. The cells in MatrigelTM were
incubated at 37ºC for 30 minutes before H14 medium was added to the gel. Regular H14
medium was used to culture S1 cells and H14 without EGF was used to culture the other
cells. The culture medium was renewed every 2-3 days.
3.2.2. Drug treatments
MDA-MB-231 cells were incubated with different reagents from day 1 to day 10
of 3D culture. Reagents used included integrin beta 1 antibody AIIB2, 15 µg/ml; Pi3K
inhibitor LY294004, 4 µM; mTOR inhibitor rapamycin, 10 nM; DMSO, 0.25% v/v.
3.2.3 Quantitative RT-PCR
Quantitative real time polymerase chain reaction (qRT-PCR) was performed by
monitoring the increase in SYBR Green fluorescence using a 7300 Real-Time PCR
machine (Applied Biosystems, Austin, TX). Primers for PUM1, CDS1 and CDS2 were
commercially obtained (SA Bioscience, Frederick, MD). The thermal cycling conditions
included one cycle at 50°C, a second denaturing step at 95°C, and 40 cycles with three
steps: 95°C for 15 seconds, 60°C for 60 seconds and 72°C for 10 seconds. Gene
transcript levels were calculated relative to PUM1 transcripts by the ΔΔCt method
(Winer, Jung, Shackel, & Williams, 1999).
3.2.4. Tumor nodule imaging and measurement
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Tumor nodules grown within the MatrigelTM were directly imaged with an IX70
microscope (Olympus). Images were taken for nodules located at different planes within
the gel layer by progressively adjusting the microscope focus. The edge of each nodule
was manually delineated on the pictures using Image J software with “free hand
selections” function. Nodule’s area and circularity were automatically obtained with the
“measurement” function. The number of protrusions from the nodule core was counted
manually as well.
3.3. Results
3.2.1.

CDS1 and CDS2 mRNA levels are gradually down-regulated in the HMT-3522

cancer progression series.
Our preliminary data have indicated that CDS1 mRNA is down-regulated in nonneoplastic S1 cells without apical polarity compared to S1 cells with apical polarity.
Also, CDS1 protein decreases in S1 cells compared to S1-derived invasive T4-2 cells
(Cardenas JM, Ph.D. Thesis, 2012). These findings suggest that the CDP-DAG
synthetase 1 is negatively correlated with malignancy. However, since vertebrate animal
cells contain two CDP-DAG synthetases, functional compensation might occur when one
is absent. To this end, both CDS1 and CDS2 mRNAs were assessed in the HMT-3522
cancer progression series by qRT-PCR. The HMT3522 series (Briand, Petersen et al.
1987; Nielsen, Madsen et al. 1994; Radisky, Muschler et al. 2002) contains nonneoplastic S1 cells at low passage (<60), S1-180 cells (high passage number S1 cell line
that mimics an hyperplasia-like structure in 3D culture), ductal carcinoma in situ
(preinvasive) S2 cells and invasive ductal carcinoma T4-2 cells, which collectively mimic
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breast cancer progression. In addition, MDA-MB-231 cells were also assayed as a control
due to its extremely low CDS1 level identified previously in the laboratory.
The qRT-PCR results show that both relative CDS1 (Fig. 3.3.1.A) and CDS2
(Fig. 3.3.1.B) mRNA levels are gradually down-regulated in the HMT-3522 cell series
when PUM1 is used as the internal reference gene (Lyng, Laenkholm et al. 2008). CDS1
mRNA is significantly reduced in S1-180 cells and further reduced in S2 and T4-2 cells.
CDS2 mRNA is significantly reduced in S2 and T4-2 cells but not in S1-180 compared to
S1 cells. These qRT-PCR results reinforce our previous hypothesis that the CDP-DAG
synthetases are negatively associated with cancer progression in the HMT-3522 model of
triple negative breast cancer.
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Figure 3.3.1 CDS1 and CDS2 mRNA expressions are down-regulated in cell lines
representing different stages of breast cancer progression.
Real-time PCR was performed from tumor nodules formed in 3D culture by the HMT3522 cancer progression series as well as from MDA-MB-231 cells. S1 represents S1
cells in lower passages (usual passage range: 53 to 60), and S1-180 means S1 cells used
in passage numbers between 178 and 187. Cells were cultured embedded in MatrigelTM
and collected on day 10, followed by RNA isolation and reverse transcription as
described in materials and methods. The mRNA expression was calculated based on the
ΔΔCt value, with the results normalized to the average Ct value of the internal control
PUM1 (n=3). T-test analyses were conducted to assess the difference between S1 and any
other groups * p<0.05; **p<0.01.
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3.3.2. Re-expressing CDS1 in MDA-MB-231 cells does not affect cell proliferation, but
it partially rescues basal polarity when combined with the inhibition of the Pi3K pathway.
Two of the most important features of cancer cell behavior are uncontrolled
proliferation and the acquisition of invasive potential. After confirming that the decrease
of CDS1 coincides with cancer progression, I wanted to know whether CDS1 influenced
cell proliferation and invasion. Cancer cell invasion is illustrated by cells breaking
through the basement membrane. This is accompanied with loss of basal polarity as
shown by breaks in the staining or a diffuse cytoplasmic staining of the basal polarity
marker beta 4 integrin. I used MDA-MB-231 cells stably transfected with CDS1 cDNA
or empty vector available in the laboratory. MDA-MB-231 cell line had been chosen for
CDS1 transfection because it displayed the lowest endogenous CDS1 level among several
breast cancer cell lines tested previously (Cardenas JM, Ph.D. Thesis, 2012). Dualstaining for cell cycle marker Ki67 and beta4 integrin was performed in CDS1 reexpressing and control vector tumor nodules produced upon 10 days of 3D cell culture. In
addition, the same dual-staining was performed on CDS1 re-expressing and control
vector cells that were subjected to several treatments targeting potential signaling
pathways that might synergize with CDS1 to tame highly aggressive MDA-MB-213
cells. Indeed it has been shown previously that these cells have to be targeted from
different angles to readily revert their aggressive phenotype (Wang, Weaver et al. 1998).
As discussed in the introduction, CDS1 pathway mediates the transition from PAs into
PIs. First, CDS1 reduction might cause PAs accumulation and PAs are also the signaling
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molecules to activate mTOR (Foster 2009), which is critical for cell survival. CDS1 reexpressing and control vector cells were incubated with mTOR inhibitor rapamycin
during the cell culture period (10 days). Second, because CDS1 locates upstream of the
Pi3K-AKT pathway, CDS1 re-expressing and control cells treated with Pi3K inhibitor
LY294002 were also investigated. At last, we incubated CDS1 re-expressing and control
cells with integrin beta1 blocking antibody that inhibits MAPK signaling necessary for
cell survival (Wang, Weaver et al. 1998).
ANOVA-Tukey analysis of the percentage of cells expressing Ki67 showed no
significant differences among any two treatments suggesting that neither re-expressing
CDS1 alone nor other combinations of CDS1 and reagents have apparent effect on
forcing MDA-MB-231 cells to quit the cell cycle (Fig. 3.3.2.A). Interestingly, when
CDS1 re-expression was combined with LY2940004, the inhibitor of Pi3K, basal polarity
is partially (schematic is shown in Figure 3.3.2.D) (Vidi, Chandramouly et al. 2012)
restored in a significant number of cells compared to the CDS1-MDA-MB-213 cells
treated with vehicle DMSO (p<0.05) (Fig. 3.3.2.B). Beta4-integrin staining at the basal
cell membrane was notably more continuous in LY treated CDS1 re-expressing cell
nodules; many of the cell nodules still could not regain full basal polarity defined as a
complete circle of basal marker around the nodule. Given that LY alone or CDS1 reexpression alone has no significant effect on the rescue of basal polarity, this result
indicates that it is the combination of CDS1 and LY that partially restores basal polarity.
Increased CDS1 mRNA level in CDS1 re-expressing cells compared to control cells was
confirmed by RT-PCR as shown in Figure 3.3.2.C.
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Figure 3.3.2.

Assessment of cell cycle activity and basal polarity in MDA-MB-231

cells transfected with CDS1 or vector control. CDS1 re-expressing cells or cells with
control vector were plated in MatrigelTM using the embedded method and treated with
rapamycin, LY, AIIB2, and the combination of AIIB2 and LY for 10 days, followed by
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staining for Ki67 to assess cell cycle status (A) or beta4-integrin to assess basal polarity
(B). One-way ANOVA-Tukey was applied to identify the potential significance for a
difference between any two treatments. The transcription level of CDS1 in CDS1 reexpressing cells and control vector cells are shown in (C). C-DMSO: CDS1-DMSO; VDMSO: vector-DMSO; C-rap: CDS1-rapamycin; V-rap: vector-rapamycin; C-LY:
CDS1-LY; V-LY: vector-LY; C-AIIB2: CDS1-AIIB2; V-AIIB2: vector-AIIB2; V-A+L:
vector-AIIB2+LY (n=3).
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3.3.3. CDS1 re-expression combined with LY treatment in MDA-MB-231 cells reduces
the size and the circularity of the tumor nodules.
To investigate the role of CDS1 in the invasive phenotype, the percentage of
tumor nodules with protrusion were assessed. Also, the size and circularity of tumor
nodules formed in 3D embedded culture were measured in MDA-MB-231 cells stably reexpressing CDS1 and compared to cells with vector control. Because all the
measurements were carried out on the images, the area size of tumor nodules was
represented by the pixels for convenience. An arbitrary length was setup as a standard for
determination of invasive protrusion and only those protrusions longer than the standard
were counted as true invasive protrusions. The percentage of tumor nodules with invasive
protrusion was obtained by comparing the number of tumor nodules containing
protrusion(s) to the total number of tumor nodules counted.
The results show that there is no significant difference regarding the percent of
nodules with invasive protrusions between LY treated and vehicle DMSO treated
transfected cells as shown in Figure 3.3.3.A., suggesting that the treatments do not
prevent MDA-MB-231 to grow invasive protrusions. The overall percentage of the
cellular nodules containing one protrusion is about 4% in CDS1 cDNA-transfected cells
and 6% in vector control cells. But the percentage of nodules containing more than one
protrusions is higher in CDS1 re-expressing cells compared to control. Although not
statistical significance, this trend is repeatedly observed in three independent replicated
experiments and the comparison of the average percentage of three replicates between
CDS1 re-expressing cells and control cells is 17% vs. 12% (data not shown). The
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percentage in A significant decrease of nodule size is observed on day10 CDS1 reexpressing cells compared to vector control under LY treatment, indicating that higher
level of CDS1 expression is negatively correlated with nodule size. The circularity of the
nodules is significantly decreased when LY is applied compared to control vehicle. This
suggests that a decrease of Pi3K signaling combined with CDS1 expression might impact
cell invasion by promoting more cell protrusions at the periphery of the tumor nodules.
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Figure 3.3.3 Assessment of invasion capabilities of the MDA-MB-231 cells overexpressing CDS1. CDS1-MDA-MB-231 and vector control cells were cultured in 3D
using the embedded method for 10 days with or without Pi3K inhibitor LY294002.
Tumor nodules were imaged on day 7 and day 10, respectively, to measure protrusions
(A), size of the nodules on day 7 and day 10 (B and C), and the circularity of the nodules
on day 7 and day 10 (D and E). Over 100 cell nodules were measured for each condition
(n = 3). The unit of area is represented by pixels. Circularity indicates the roundness of
the object. The largest value 1 means perfect circle. * p<0.05; ** p<0.01
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3.4. Discussion
The CDS pathway is so far the only mechanism identified that generates
phosphatidylinositols from phosphatidic acid. Because this pathway involves multiple
phosphalipid signal molecules, especially phosphatidylinositides, that are pivotal for cell
proliferation, growth, survival, cell-cell adhesion, molecules trafficking, and cell skeleton
arrangement (Toker and Cantley 1997), deregulation of CDP-DAG synthetase expression
is likely to affect cell activities profoundly. At present, CDS2 is known to control
angiogenesis during development in zebrafish (Pan, Pham et al. 2012), but the potential
similar function of its homologs in higher vertebrates still needs to be confirmed and
other functions might also be discovered.
Previous work in our laboratory identified CDS1 to be down-regulated upon the
disruption of apical polarity in non-neoplastic S1 cells and its expression further reduced
in invasive T4-2 cells (Cardenas JM, Ph.D. Thesis, 2012). To rule out the possibility that
CDS2 might compensate for the loss of CDS1 function, I investigated CDS1 and CDS2
mRNA levels in HMT-3522 breast cancer progression cell series. My results show that
CDS mRNA levels are decreased during cancer progression, which is consistent with the
previous finding in our laboratory that CDS1 expression decrease is associated with
estrogen receptor negative (ER-) invasive breast cancer in archival clinical samples
(Cardenas JM, Ph.D. Thesis, 2012). Especially, to give further details on previously
obtained results, CDS1 expression was characterized in normal tissue and breast cancer
with a semi-quantitative immunohistochemistry technique by Cardenas (Cardenas JM,
Ph.D. Thesis, 2012). The results revealed a decrease of CDS1 in some cancer tissues and
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statistical analysis identified a significant association between low CDS1 level and
estrogen receptor negative breast cancer. CDS1 mRNA level and protein level in
different cancer cell lines were also assessed with qPCR and western blot, respectively.
In HMT-3522 series mimicking triple negative breast cancer progression, the decrease of
CDS1 mRNA level was concomitant with cancer progression. CDS1 was decreased
mostly in a ER negative breast cancer cell line MDA-MB-231, while it was not
significantly changed in MCF7 and BT20 cancer cell lines. Western blot analysis of
CDS1 revealed an interesting pattern of doublet bands in specific cell lines. Nonneoplastic S1 cells showed a strong expression of lower band while their invasive
counterpart T4-2 cells displayed a strong expression of the upper band of the doublet.
While MCF7 cell line only showed the lower band of CDS1, the highly invasive cell line
MDA-MB-231 only showed higher band. Overall, it seems that the expression of CDS1
in different cell lines is mostly associated with the degree of invasiveness, but more
evidence should be obtained to support this hypothesis. These preliminary results
logically led us to investigate the role of CDS1 in cell proliferation control and invasion.
Over expressing CDS1 in ER(-) invasive breast cancer cell line MDA-MB-231 failed to
induce actively dividing cells to exit the cell cycle as indicated by Ki67
immunofluorescence staining, suggesting that CDS1 does not influence proliferation in
these breast cancer cells. Ki67 staining in CDS1-re-expressing cells subjected to other
potentially phenotype-reverting treatments like the inhibition of mTOR or Pi3K pathways
did not reveal a difference either when compared to the corresponding controls. This
observation suggests that re-expression of CDS1 is not able to prevent cell from
proliferating. In Drosophila cds mutant, the cell number in salivary gland is not changed
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although a decrease in cell size has occurred (Liu, Wang et al. 2014), which seems in
agreement with my result regarding cell cycle activity but it will be important to also
assess a possible change in cell size in the MDA-MB-213 cells. However, data from
Drosophila also indicated that CDS function is cell-type dependent, thus we cannot rule
out the possibility that CDS1 affects the cell cycle in other types of human cancer cells.
In my present study, Ki67 staining only indicates whether the cells are still in the cell
cycle, but without analyzing the distribution pattern for Ki67 or analyze the expression of
cyclins, I cannot determine if a specific phase of the cell cycle is extended. I have
observed a decrease of total cell number upon the combined treatments with the Pi3K
inhibitor and beta1 integrin blocking antibody regardless the re-expression of CDS1
compared to other treatments, but the percentage of cells positive for Ki67 still remains
high. This situation could be due to the slow proliferation of these cells without cell cycle
exit. Flow cytometry-based cell cycle analysis should provide more information about
CDS1’s potential role in cell cycle control.
Disruption of the integrity of the basement membrane is the hallmark of cancer
progression to the invasive stage. This is usually associated with the redistribution of
basal polarity markers like beta4 integrin. It is important to find out if CDS1 reexpression alone or rather combined with other drug treatments that are supposed to tame
breast cancer cells can restore polarity. If so, CDS1 might function in preventing
invasion. It should be noted that none of the treatments could fully restore the basal
polarity in the MDA-MB-213 tumor nodules, but some nodules did display a
discontinuous staining of integrin beta4 at the edge, which was defined in a previous
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study as partial basal polarity (Vidi, Chandramouly et al. 2012). By re-expressing CDS1
or inhibiting the Pi3K pathway alone, no significant difference regarding basal polarity
was found compared to control cells. But when CDS1 re-expression was combined with
Pi3K pathway inhibition, an improvement of partial basal polarity was observed. This
might lead to two possibilities including that both Pi3K activation and lack of CDS1
contribute to cancer invasion via different pathways, or that their effects are additive. We
will need to assess the potential changes of PIs level or Pi3K activity in MDA-MB-231
cells after CDS1 re-expression in order to pin down the signaling pathways influenced by
CDS1 with regards to polarity.

The activation of the ERK pathway induces the

expression of matrix metalloproteinase-9 (Chung, Lee et al. 2004), which, in turn,
degrades the basement membrane components and thus, promotes invasion. In human
endothelial HUVEC cells with silenced CDS1 or CDS2, phosphorylated ERK (pERK) is
abolished and accordingly, the invasion is alleviated (Pan, Pham et al. 2012). However, in
our case, pERK level is decreased in CDS1 re-expressing cells compared to control
vector cells (data not shown), indicating that breast epithelial cells might respond
differently to changes in CDS1 expression level compared to endothelial cells. The
decrease of pERK in CDS1-MDA-MB-231 cells might explain the recovery of basal
polarity if MMP activity is changed by such a decrease. Overall, PI and PA levels should
be quantified in CDS1 re-expressing cells to narrow down the altered signaling pathways
so that we can better understand the contributions from the potential signaling pathways
to cancer invasion.
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Several invasiveness-related characteristics including protrusion, area, and
circularity of the cell nodules were assayed under the combined CDS1 re-expression and
Pi3K inhibition in order to determine the potential preventive effects of the treatment.
Our results showed no difference regarding the percentage of nodules with protrusions
between treatments and control, suggesting that the observed partial restoration of basal
polarity is not able to prevent cells from penetrating into the extracellular matrix. A
significant decrease in nodule circularity was found in CDS1 re-expressing cells
combined with Pi3K inhibition compared to vector control cells treated with Pi3K
inhibition, suggesting that CDS1 promotes the shape of tumor nodules to be more
irregular. With the same overall percentages of nodules containing invasive protrusions
between treatment and control, a more detailed examination of the number of the
protrusions on each nodule revealed that CDS1 re-expressing cells made more nodules
with multiple protrusions, while vector control cells made more nodules with a single
protrusion. This observation might explain the difference of circularity. In addition, my
data showed that CDS1 re-expressing nodules are smaller in size compared to control at
day 10 of culture. Several factors could influence nodule size in this study. First, CDS1
expression level was reported to directly determine cell size in Drosophlia (Liu, Wang et
al. 2014). Second, the existence of basal polarity affects nodule size by protecting the
cells from treatment with cytotoxic drugs and promoting cell proliferation, which
eventually increases the size of cellular nodules (Weaver, Lelievre et al. 2002).
Alternatively, basal polarity generates mechanical force at the periphery of the tumor
nodule to maintain multiple cells into a tight spheroid structure. At last, cell death is also
a factor contributing to the nodule size. Thus, in future experiments we need to verify that
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the smaller size is not due to increased cell death or decreased cell size (Liu, Wang et al.
2014).
Collectively, we found that CDS1 re-expression when the Pi3K pathway is
inhibited led to more invasive growth (less circularity) but smaller size for MDA-MB231 cell nodules. But the mechanisms underlying these phenotypes need further
investigation. A logical explanation based on the CDS signaling pathway should be that
re-expression of CDS1 increases PIs level, which in turn elevates Pi3K-AKT pathway. It
is known that the disruption of apical polarity (Bakin, Tomlinson et al. 2000) as well as
the invasive growth (less circularity) are both the consequences of the increased Pi3K
activity.

Although Pi3K inhibitor was applied to the cells, its effect could be

compromised by the re-expression of CDS1 and that could be the reason for the
treatments still displaying the difference between CDS1 re-expressing and vector control
cells. The correlation of ER- breast cancer at invasive stage and the down-regulation of
CDS1 seems to indicate that CDS1 upstream molecules (PAs)-mediated pathways play a
more important role at the invasive stage in this subtype breast cancer, possibly involved
in the activation of MMPs to further disrupt basal polarity. Thus, the CDS protein could
play a dual role in basoapical polarity control. Its expression level might have to increase
to disrupt the apical polarity through producing more PIs, but as soon as the apical
polarity is impaired, its level quickly decreases to accumulate more PAs to facilitate
invasion progression. To this respect, Pi3K-AKT activity and PA mediated pathways
corresponding to the change of CDS1 expression should be the targets for the future
investigation.
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In the present study, I have focused on the role of CDS1 in invasion-related basal
polarity. But how CDS1 is correlated with apical polarity still remains unsolved. We have
initiated a study to look for genes co-expressing with CDS1 in Oncomine database
(https://www.oncomine.org/). By setting-up the correlation coefficient at greater than 0.7
(a moderate to strong correlation), I cross-checked the selected genes from different
datasets. Very interestingly, when the selected genes were arranged by appearing
frequency, some of the top genes are tight junction and adherens junction proteins, such
as EPCAM, Claudin 4, E-cadherin, and so on (data not shown). Because co-expressing
genes are usually considered functionally related, this result supports our hypothesis that
CDS1 is linked to apical polarity. Investigating these genes expression profile in CDS1
re-expressing or silenced non-neoplastic cells could bring more information about how
CDS1 might regulate apical polarity.
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CHAPTER 4: FINAL DISCUSSION

Cells are the smallest units in the body to conduct basic biological functions such
as differentiation, growth, proliferation, aging, and death. All these aspects contain risk to
initiate cancer if any function cannot be executed appropriately. Therefore, to understand
the cells is a fundamental prerequisite for cancer prevention.

Lipids, proteins, and

nucleic acids are the essential materials that compose a cell. These cellular entities further
assemble into functional complexes at different levels with distinct structures. The
arrangement of these functional complexes in a spatial and temporal manner forms the
cell organization. Since the cell was first described by Robert Hooke in 1665, every
discovery on cell organization has broadened our knowledge of the cell to a new level.
This can be best exemplified by the understanding of the double-helix structure of DNA
in 1953 that opened the epoch of modern molecular genetics. Indeed, the appropriate cell
organization is the structural basis to guide cellular homeostasis. In order to understand
the influence of mammary epithelial cell organization on breast cancer initiation and
progression, my current research is focused on two proteins, NuMA and CDS1, which are
respectively related to cell nucleus organization and basoapical polarity.
Our laboratory previously reported that NuMA organizes higher order chromatin
(Abad, Lewis et al. 2007) and affects nucleolar transcription (Jayaraman S, Ph.D. 2014).
In the present study, I proposed that NuMA regulates nucleolar organization and function
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through its interaction with cohesin. My results show that silencing NuMA can change
nucleolar organization and that NuMA and cohesin are preferentially enriched in the
rDNA IGS region. Preliminary results further indicate a possible role for NuMA in rDNA
looping regulation, thereby, the immediate next step is to test the hypothesis that NuMA
is involved in rDNA loops using 3C-qPCR technique (Hagege, Klous et al. 2007).
Transcription termination factor TTF-I generates a rDNA loop by tethering its two
binding sites flanking the rDNA coding region (Nemeth, Guibert et al. 2008). Yet,
NuMA and cohesin were not particularly enriched in TTF-I binding sites (Figure 2.3.5
B&C, region pro-1 and H13) in my study, rather, NuMA/cohesin might control the rDNA
loops at IGS regions (Figure 2.3.5 B&C, region H27 and H32). If this is the case,
NuMA/cohesin might interact with MYC protein, which was demonstrated to bind rDNA
IGS (Shiue, Nematollahi-Mahani et al. 2014). The assessment for the potential interaction
between NuMA and MYC (or TTF-I) using co-IP should permit the identification of
NuMA’s binding partner and thus, provides more information about the rDNA looping
structure. It is highly possible that the size of rDNA loops is not uniform given the fact
that not all rDNA genes in the nucleolus are active at the same time. Different epigenetic
statuses on the rDNA chromatin regions might allow the co-existence of several types of
loops mediated by distinct proteins. To this end, NuMA/cohesin, MYC, and TTF-I might
co-exist for rDNA looping regulation.
The redistribution of Pol I indicated by staining of Pol I large subunit RPA194
was observed in the nucleolus upon NuMA silencing, but it is not clear if this is due to
the direct binding of NuMA and RPA194, or mediated via a third party. Surprisingly, I
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also observed a subpopulation of, if not all, RPA194 aggregating at the spindle poles and
overlapping with NuMA during mitosis (data not shown). According to the existing
evidence, transcriptionally inactive Pol I disassembles during the mitosis: some subunit
like RPA43 stay with the NORs during mitosis while other subunits like RPA40,
RPA194, and RPA16 are dissociated from the chromosomes (Leung, Gerlich et al. 2004;
Chen, Dundr et al. 2005), but the destination of RPA194 was not reported, and other
dissociated subunits were not shown to appear at spindle poles based on my literature
search. Therefore, this observation might be a novel finding and its biological meaning is
not clear. Interestingly, RPA194 behaves similarly as cohesin during the mitosis, which
is also aggregating at the spindle poles where it interacts with NuMA through Rae 1 as
discussed earlier (Gregson, Schmiesing et al. 2001; Wong and Blobel 2008). Is the
presence of RPA194 at spindle poles linked to cohesin or NuMA? Is the presence of
RPA194 at spindle poles critical for theformation of the poles and mitotic progression? Is
this another mechanism by which the nucleolus controls the cell cycle? All these answers
are awaited.
The result of the FUrd assay of nascent RNAs in NuMA silenced cells indicated
that the absence of NuMA not only reduces rRNA production but also possibly mRNA
production, which suggests a global role of NuMA in RNA transcription. This is
consistent with the Lelièvre laboratory earlier results showing that NuMA controls
chromatin organization in the whole nucleus. The interaction of NuMA and cohesin
possibly exists genome-wide and is not confined in the nucleolar region. Several results
from the study of the binding partners for estrogen receptor alpha (ERα) as well as ERα
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binding sites on the chromatin might shed light on this aspect.

First, NuMA was

identified as one of activated ERα binding partners (Cheng, Chang et al. 2010; Tarallo,
Bamundo et al. 2011). Second, cohesin and ERα co-occupy at regulatory elements
(enhancer and promoter) of hundreds of estrogen responsive genes and cohesin binding to
these regions is independent of CTCF (Fullwood, Liu et al. 2009; Schmidt, Schwalie et
al. 2010). Collectively, evidence suggests that NuMA and cohesin might coordinate the
local chromatin conformation of ERα responsive genes upon estrogen stimulation. This
hypothesis can be tested by studying the chromatin loop structure at regulatory elements
and gene transcription of one ERα regulated gene, like MYC (McEwan, Eccles et al.
2012). These experiments might also help answer the critical question –of how NuMA
influences cell quiescence in mammary epithelial cells.
Finally, with the help of 3C derived high-throughput techniques combined with
DNA sequencing and big data analysis, the role of NuMA in higher order chromatin
organization will be eventually unraveled.
In the light of the established importance of basoapical polarity on cancer
initiation and progression, CDS1 was studied, especially for its role in basal polarity and
invasion control.

The results suggested that re-expression of CDS1 promotes the

integrity of basal polarity but does not prevent the invasive growth in highly invasive
MDA-MB-231 cells under our experimental conditions.

The signaling pathways

influenced by CDS1 re-expression were not identified yet as my goal in this study was to
mainly assess the impact of CDS1 on polarity-related phenotypes. In future steps,
because many phospholipid molecules and signaling pathways are connected to CDS1’s
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function, it would be wise to first identify the phospholipid molecules with a significant
change in expression level upon CDS1 re-expression in MDA-MB-231 cells.
Based on microarray analysis and CDS1 being related to PI3K pathways, apical
polarity establishment or maintenance is another feature that CDS1 might influence and
that might link it with cancer initiation. In order to assess CDS1’s impact on apical
polarity reproduced in a 3D cell culture system, I have tried to constitutively silence
CDS1 in HMT-3522 S1 cells with shRNA, yet I could not obtain stably transfected cells
due to the difficulty of transfecting the non-neoplastic S1 cells in general. More effort
will be conducted in the future to generate S1 cells with CDS1 silenced by using other
methods, like viral infection.
In summary, I studied the cell architecture with respect to basoapical polarity and
nuclear organization through CDS1 and NuMA, respectively. My work improved our
understanding of the cell architecture and cell architecture-controlled activities such as
proliferation and invasive growth. Especially for the nucleolus, which is essential for
ribosome biogenesis, nuclear stress perception, and cell cycle regulation, I have shown
that NuMA influences nucleolar architecture and rDNA transcripition, likely in
association with altered proliferation. The elevated activity of the nucleolus is necessary
to promote cancer growth and thus, the nucleolus is a promising drug target for cancer
intervention (Quin, Devlin et al. 2014). My study of NuMA helps understand more
mechanisms by which the nucleolar activities are controlled. My study also suggested
that CDS1 protects the integrity of the basal polarity and influences the size and
invasiveness of tumor nodules in the cancer cells studied. Given that CDS1 potentially
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conducts the regulation of both apical polarity and basal polarity, it plays a unique role in
cell architecture control. The biological events corresponding to apical polarity and basal
polarity are cell proliferation control and survival. Thus, CDS1 could link both functions
on its own, which makes it a potential valuable protein for pharmaceutical purpose.
At the whole cell organization level, the two aspects, basoapical polarity and
nuclear organization, are deep down interdependent instead of separated, as earlier
studies already established the communication between basal polarity and nuclear
organization (Lelievre and Bissell 1998; Lelievre, Weaver et al. 1998; Vidi,
Chandramouly et al. 2012), as well as the link between apical polarity and nuclear
organization (Abad, Lewis et al. 2007; Chandramouly, Abad et al. 2007). Under these
different circumstances NuMA seems to play a central role to sense and react to the
signals sent by polarity and to be responsible for the arrangement of nuclear organization
accordingly. To this sense, NuMA’s behavior fits very well with that of a nuclear stress
sensor, which just started to emerge from its functions in regulating the nucleolus. The
whole picture of the cell organization reflects the complexity but also the beauty of the
cell - everything is connected!
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